syndrome	score	normalized_score
OCULOFACIOCARDIODENTAL SYNDROME	2.0	100.0
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	1.2909091	64.54545499999999
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	1.20384615	60.1923075
BEHR SYNDROME	1.2011498	60.05749
260150 PALANT CLEFT PALATE SYNDROME	1.16829038	58.414519
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	1.074490938	53.7245469
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	1.00291038	50.14551900000001
DUPLICATION OF THE PITUITARY GLAND	1.00162338	50.081169
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	1.00162338	50.081169
ANAPLASTIC THYROID CARCINOMA	1.0	50.0
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.83462	41.731
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.82930038	41.465019
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	0.79684233	39.8421165
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.6969696000000001	34.84848
15Q OVERGROWTH SYNDROME	0.666666	33.3333
MUCOPOLYSACCHARIDOSIS TYPE 2	0.5833333	29.166665000000002
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.5633307399999999	28.166536999999998
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.56159726	28.079863
NON-DISTAL MONOSOMY 20Q	0.515667438	25.783371900000002
WIEACKER-WOLFF SYNDROME	0.515298638	25.7649319
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.5126582	25.63291
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.50719424	25.359712000000002
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.50384615	25.1923075
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.50359712	25.179856
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.501287	25.06435
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.5	25.0
BRANCHIOOTORENAL SYNDROME 1	0.5	25.0
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.5	25.0
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.5	25.0
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.5	25.0
DISTAL 17P13.1 MICRODELETION SYNDROME	0.5	25.0
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.5	25.0
MYOPATHIC EHLERS-DANLOS SYNDROME	0.4700791	23.503955
ULNAR HEMIMELIA	0.4455281	22.276405
ANOCTAMIN-5-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R12	0.4383321	21.916605
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.39377987999999997	19.688993999999997
GLOMUVENOUS MALFORMATION	0.392857	19.64285
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.3765852	18.82926
BILATERAL POLYMICROGYRIA	0.37386124000000004	18.693062
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.37166509999999997	18.583254999999998
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.36781579999999997	18.39079
EMERY-NELSON SYNDROME	0.33814068999999997	16.907034499999998
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.333333	16.66665
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.333333	16.66665
NEUROMYELITIS OPTICA	0.333333	16.66665
EPIDERMAL NEVUS SYNDROME	0.333333	16.66665
FRASER-LIKE SYNDROME	0.333333	16.66665
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.333333	16.66665
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.2934783	14.673915000000001
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.2924201	14.621005
SCHWARTZ-JAMPEL SYNDROME	0.28857952000000003	14.428976000000002
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.2822581	14.112905000000001
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.26762853799999997	13.3814269
STUVE-WIEDEMANN SYNDROME	0.263910438	13.195521900000001
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.2588235	12.941175
MUCOPOLYSACCHARIDOSIS TYPE 1	0.25359712	12.679856000000001
MICROPHTHALMIA WITH LIMB ANOMALIES	0.25291038	12.645519
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.252584918	12.629245899999999
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25162338	12.581169000000001
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.251287	12.56435
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.25	12.5
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.25	12.5
WILD TYPE ABETA2M AMYLOIDOSIS	0.25	12.5
SCLERODERMA	0.25	12.5
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.25	12.5
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	12.5
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.24754072	12.377036
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.2371406	11.85703
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.210589738	10.5294869
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.20675653000000002	10.3378265
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20409836	10.204918000000001
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.20258491800000003	10.1292459
RIGID SPINE SYNDROME	0.200656938	10.032846900000001
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.2	10.0
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.2	10.0
MALARIA	0.2	10.0
BENIGN SCHWANNOMA	0.2	10.0
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.2	10.0
FAMILIAL CERVICAL ARTERY DISSECTION	0.2	10.0
RADIATION PROCTITIS	0.2	10.0
POLYARTERITIS NODOSA	0.2	10.0
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	10.0
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.2	10.0
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.1895349	9.476745000000001
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.1895349	9.476745000000001
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.1895349	9.476745000000001
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.1895349	9.476745000000001
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.1895349	9.476745000000001
ROBERTS SYNDROME	0.18917957999999999	9.458979
ZUNICH NEUROECTODERMAL SYNDROME	0.18905297800000004	9.452648900000002
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.17932520000000002	8.96626
DUPUYTREN CONTRACTUREDUPUYTREN CONTRACTURE 1, INCLUDED	0.17932520000000002	8.96626
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.1773398	8.86699
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.17511509999999997	8.755754999999999
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.17477139800000002	8.738569900000002
PERMANENT NEONATAL DIABETES MELLITUS	0.17386124	8.693062
TRANSIENT NEONATAL DIABETES MELLITUS	0.17386124	8.693062
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.17213653	8.6068265
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.1719736	8.59868
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.17180015	8.5900075
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.17180015	8.5900075
PRADER-WILLI SYNDROME	0.17155112	8.577556
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.17147468800000001	8.573734400000001
MUCOLIPIDOSIS TYPE II	0.17026412000000002	8.513206
SMITH-KINGSMORE SYNDROME; SKS	0.168915538	8.4457769
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.16795400000000002	8.3977
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.16795400000000002	8.3977
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.166667	8.333350000000001
CRANIOACROFACIAL SYNDROME	0.166667	8.333350000000001
DERMATOLEUKODYSTROPHY	0.166667	8.333350000000001
FASCIAL DYSTROPHY, CONGENITAL	0.166667	8.333350000000001
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.166667	8.333350000000001
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.166667	8.333350000000001
SYNPOLYDACTYLY 1	0.166667	8.333350000000001
UNILATERAL POLYMICROGYRIA	0.166667	8.333350000000001
PORPHYRIA	0.166667	8.333350000000001
PEYRONIE DISEASE	0.166667	8.333350000000001
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	8.333350000000001
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.166667	8.333350000000001
CEREBROOCULONASAL SYNDROME	0.166667	8.333350000000001
GRAFT VERSUS HOST DISEASE	0.166667	8.333350000000001
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.166667	8.333350000000001
CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	0.1625	8.125
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.15699616	7.8498079999999995
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.15275873	7.6379365
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.14695535999999998	7.3477679999999985
FREE SIALIC ACID STORAGE DISEASE	0.14645412	7.322705999999999
AMISH NEMALINE MYOPATHY	0.1458333	7.291665
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.14285699999999998	7.142849999999999
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.14285699999999998	7.142849999999999
FAMILIAL MULTIPLE NEVI FLAMMEI	0.14285699999999998	7.142849999999999
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.14215680000000003	7.107840000000001
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.14215680000000003	7.107840000000001
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.13576980000000002	6.788490000000001
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.135328338	6.766416899999999
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.134766538	6.7383269
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.13298877	6.6494385000000005
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.13219424	6.609711999999999
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.12724853800000002	6.362426900000001
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.12521959800000002	6.260979900000001
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.125	6.25
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.125	6.25
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.125	6.25
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.125	6.25
SEVERE HEMOPHILIA A	0.125	6.25
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.12246818000000002	6.123409000000001
FRONTOMETAPHYSEAL DYSPLASIA	0.12246399000000001	6.1231995
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.12168609000000001	6.084304500000001
ROBERTS SYNDROME; RBS	0.12056668	6.028334
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.11830523999999999	5.915261999999999
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.11438980000000001	5.71949
TERMINAL OSSEOUS DYSPLASIA; TOD	0.11302017	5.6510085000000005
FG SYNDROME TYPE 1	0.11239799999999998	5.6198999999999995
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.11207253799999999	5.603626899999999
HYALINE FIBROMATOSIS SYNDROME; HFS	0.11111099999999999	5.555549999999999
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.11111099999999999	5.555549999999999
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.11111099999999999	5.555549999999999
JUVENILE HYALINE FIBROMATOSIS	0.11111099999999999	5.555549999999999
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.10978583800000001	5.4892919000000004
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.10815050000000001	5.407525000000001
GENITOPATELLAR SYNDROME; GTPTS	0.10716863800000001	5.3584319
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.10401489800000001	5.2007449
RARE CIRCULATORY SYSTEM DISEASE	0.10310420000000001	5.15521
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.10310420000000001	5.15521
AICARDI SYNDROME; AIC	0.102595088	5.1297544
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.100961538	5.0480769
CAMPTOBRACHYDACTYLY	0.1	5.0
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.1	5.0
MARDEN-WALKER SYNDROME	0.09894772800000001	4.947386400000001
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.0972785	4.863925
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.09640188799999999	4.8200943999999994
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.09599150000000001	4.799575000000001
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.09599150000000001	4.799575000000001
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.09571679000000001	4.785839500000001
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.09571678800000001	4.7858394
MARINESCO-SJÖGREN SYNDROME	0.09475525000000001	4.7377625000000005
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.09397259000000001	4.6986295
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.09381948	4.690974
OCULODENTODIGITAL DYSPLASIA; ODDD	0.09253248	4.626624
WT LIMB-BLOOD SYNDROME	0.0921961	4.609805
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.09219119800000002	4.609559900000001
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.09173810800000001	4.586905400000001
POSTAXIAL TETRAMELIC OLIGODACTYLY	0.0909091	4.5454550000000005
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.0909091	4.5454550000000005
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.0909091	4.5454550000000005
KUFOR-RAKEB SYNDROME	0.0909091	4.5454550000000005
SAGLIKER SYNDROME	0.0909091	4.5454550000000005
TRISOMY 18P	0.0909091	4.5454550000000005
TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF	0.0909091	4.5454550000000005
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.0909091	4.5454550000000005
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.0909091	4.5454550000000005
CORNEODERMATOOSSEOUS SYNDROME	0.0909091	4.5454550000000005
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.09067422000000001	4.533711
8P INVERTED DUPLICATION/DELETION SYNDROME	0.08846645000000002	4.423322500000001
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.08843139000000001	4.4215695
CAMPTODACTYLY-TAURINURIA SYNDROME	0.08814099000000002	4.407049500000001
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.08742150000000001	4.371075
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.08717945000000002	4.358972500000001
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.0861345	4.306725
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.0861345	4.306725
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.0858267	4.291335
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.08567025000000002	4.2835125000000005
BLAU SYNDROME	0.08567025000000002	4.2835125000000005
3Q29 MICRODUPLICATION SYNDROME	0.08495668	4.247834
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.08462030000000001	4.231015
6Q TERMINAL DELETION SYNDROME	0.08420332000000001	4.210166000000001
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	0.08333330000000001	4.166665000000001
POSTPOLIOMYELITIS SYNDROME	0.08333330000000001	4.166665000000001
METACHONDROMATOSIS	0.08333330000000001	4.166665000000001
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.08333330000000001	4.166665000000001
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.08333330000000001	4.166665000000001
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.08333330000000001	4.166665000000001
CORACOCLAVICULAR JOINT, ANOMALOUS	0.08333330000000001	4.166665000000001
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.08333330000000001	4.166665000000001
MONOSOMY 22	0.08333330000000001	4.166665000000001
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.08333330000000001	4.166665000000001
KENNERKNECHT SYNDROME	0.08333330000000001	4.166665000000001
MANDIBULOACRAL DYSPLASIA	0.08333330000000001	4.166665000000001
BOWEN-CONRADI SYNDROME	0.08333330000000001	4.166665000000001
LARON SYNDROME	0.08333330000000001	4.166665000000001
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.08333330000000001	4.166665000000001
CALCIFICATION OF JOINTS AND ARTERIES; CALJA	0.08333330000000001	4.166665000000001
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.081685178	4.0842589
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.08153494	4.076747
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.07983340800000001	3.9916704000000003
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.07962408800000001	3.9812044000000006
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.07866255	3.9331275
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.07862284000000001	3.931142000000001
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.07758196	3.8790980000000004
URBAN-ROGERS-MEYER SYNDROME	0.07752329000000001	3.8761645000000002
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.0773367	3.8668349999999996
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.07648849800000002	3.824424900000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.07623628800000001	3.8118144000000007
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.07623628800000001	3.8118144000000007
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.07598959999999999	3.7994799999999995
HALLERMANN-STREIFF SYNDROME; HSS	0.07560372	3.780186
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.07527475000000002	3.763737500000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.07527475000000002	3.763737500000001
TURNPENNY-FRY SYNDROME; TPFS	0.07524112	3.762056
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.074930438	3.7465219000000003
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.07405604	3.702802
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.07389253800000001	3.6946269000000003
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.0737813	3.689065
BRAIN-LUNG-THYROID SYNDROME	0.0735294	3.6764699999999997
16Q24.3 MICRODELETION SYNDROME	0.0727156	3.6357800000000005
CEREBROFACIOARTICULAR SYNDROME	0.07259496	3.629748
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.072390138	3.6195069
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.072145188	3.6072594
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.07142860000000001	3.5714300000000003
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.07142860000000001	3.5714300000000003
CONGENITAL HYDROCEPHALUS	0.07142860000000001	3.5714300000000003
LETHAL CONGENITAL CONTRACTURE SYNDROME 6; LCCS6	0.07142860000000001	3.5714300000000003
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07142860000000001	3.5714300000000003
LOCALIZED SCLERODERMA	0.07142860000000001	3.5714300000000003
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.07142860000000001	3.5714300000000003
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.07142860000000001	3.5714300000000003
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.07098874000000001	3.5494370000000006
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.07061938	3.530969
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.06929825	3.4649125000000005
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0687645	3.438225
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.068713608	3.4356804
EVEN-PLUS SYNDROME	0.0673375	3.366875
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.067228308	3.3614154
LETHAL CONGENITAL CONTRACTURE SYNDROME 4; LCCS4	0.0667341	3.3367050000000003
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.06565853	3.2829265000000003
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.06429303	3.2146515
DISTAL MONOSOMY 10Q	0.06429303	3.2146515
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.06412338	3.2061689999999996
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.063883398	3.1941699
OTOONYCHOPERONEAL SYNDROME	0.0637945	3.189725
CHROMOSOME 1P36 DELETION SYNDROME	0.06294879799999999	3.1474398999999993
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.06266965000000001	3.1334825000000004
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.06164708	3.082354
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.06156017	3.0780084999999997
KAPUR-TORIELLO SYNDROME	0.06156017	3.0780084999999997
HYDROLETHALUS SYNDROME 1	0.06044688	3.022344
OROFACIODIGITAL SYNDROME I; OFD1	0.06044688	3.022344
SECKEL SYNDROME 5; SCKL5	0.0601105	3.005525
PIERPONT SYNDROME	0.0601105	3.005525
TENORIO SYNDROME; TNORS	0.059785038	2.9892518999999997
SPINOCEREBELLAR ATAXIA TYPE 2	0.059785038	2.9892518999999997
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.05977446	2.9887230000000002
GABRIELE-DE VRIES SYNDROME	0.0594712	2.97356
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.0588235	2.941175
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.0588235	2.941175
BETHLEM MYOPATHY	0.05836648999999999	2.9183244999999998
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.0574235	2.871175
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.056656288000000006	2.8328144
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.0557817	2.789085
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.05548023	2.7740115
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.05548023	2.7740115
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.0551563	2.757815
WITTEVEEN-KOLK SYNDROME	0.054880137999999995	2.7440068999999996
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.054544458000000004	2.7272229
MICROPHTHALMIA, SYNDROMIC 1	0.054307698	2.7153849
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.05425498	2.712749
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.053593138	2.6796569
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.053593138	2.6796569
MUCOLIPIDOSIS IV; ML4	0.053593138	2.6796569
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.053593138	2.6796569
JOUBERT SYNDROME 23; JBTS23	0.0526316	2.63158
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.052097837999999994	2.6048918999999997
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.051391059999999995	2.569553
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.051065598	2.5532798999999997
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.05067254	2.533627
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.05067254	2.533627
HYPEREKPLEXIA 4; HKPX4	0.050621160000000005	2.5310580000000003
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.049784959999999996	2.489248
ERYTHERMALGIA, PRIMARY	0.0494995	2.474975
OROFACIODIGITAL SYNDROME XIV; OFD14	0.04890473799999999	2.4452368999999994
PALLISTER-HALL SYNDROME	0.04861145	2.4305725000000002
OROFACIODIGITAL SYNDROME TYPE 6	0.047663518	2.3831759
CORNELIA DE LANGE SYNDROME 1	0.04736358	2.368179
BETHLEM MYOPATHY 1	0.04730579	2.3652895
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.0466779	2.333895
JOUBERT SYNDROME 1	0.046040137999999994	2.3020069
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.045967240000000006	2.2983620000000005
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.0456866	2.28433
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.045078599999999996	2.25393
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.044439838	2.2219919
MOSAIC TRISOMY 1	0.04422139	2.2110695
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.04396906	2.1984529999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.04391676	2.195838
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.043478300000000004	2.173915
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.04343520799999999	2.1717603999999993
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.0429612	2.14806
AICARDI SYNDROME	0.04281005	2.1405025
GENITOPATELLAR SYNDROME	0.04197274	2.098637
THROMBOCYTOPENIA 1	0.041692059999999996	2.084603
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.04120945	2.0604725
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.041186669999999995	2.0593334999999997
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.040326888000000005	2.0163444000000004
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.04022264	2.011132
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.04008488	2.0042440000000004
BLACKFAN-DIAMOND ANEMIA	0.04008488	2.0042440000000004
16P13.11 MICRODELETION SYNDROME	0.039976170000000005	1.9988085000000002
2Q31.1 MICRODELETION SYNDROME	0.039976170000000005	1.9988085000000002
WIDOW'S PEAK SYNDROME	0.039748500000000006	1.9874250000000002
3Q13 MICRODELETION SYNDROME	0.039748500000000006	1.9874250000000002
VELOCARDIOFACIAL SYNDROME	0.039748500000000006	1.9874250000000002
MELAS	0.039452339999999995	1.9726169999999998
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.03929049	1.9645244999999998
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0384615	1.923075
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.0384615	1.923075
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.923075
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0384615	1.923075
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0384615	1.923075
WILSON DISEASE	0.0384615	1.923075
ALSTROM SYNDROME; ALMS	0.0384615	1.923075
MYCETOMA	0.0384615	1.923075
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.0384615	1.923075
FABRY DISEASE	0.0384615	1.923075
DERMOCHONDROCORNEAL DYSTROPHY	0.0384615	1.923075
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.0384615	1.923075
EPISODIC ATAXIA, TYPE 1; EA1	0.0384615	1.923075
245800 LAURENCE-MOON SYNDROME	0.0384615	1.923075
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0384615	1.923075
MUCOLIPIDOSIS III GAMMA	0.0384615	1.923075
MICROPHTHALMIA, LENZ TYPE	0.03835279	1.9176395
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.03820158	1.9100789999999999
FETAL AKINESIA DEFORMATION SEQUENCE	0.03816811	1.9084055
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.03807992	1.9039960000000002
3C SYNDROME	0.0374786	1.87393
FIBROCHONDROGENESIS 1; FBCG1	0.03613034	1.806517
THUMBS, CONGENITAL CLASPED	0.0361093	1.8054649999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.035990718000000005	1.7995359000000002
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.03585522	1.792761
SAY-BARBER-MILLER SYNDROME	0.03557426	1.7787130000000002
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.035444338	1.7722168999999999
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.035444338	1.7722168999999999
RESTRICTIVE DERMOPATHY	0.03525773	1.7628865
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.03516848	1.7584240000000002
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.03511488	1.755744
TRICHOTHIODYSTROPHY	0.03493829799999999	1.7469148999999997
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.03465178	1.732589
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.0344828	1.72414
MYOPATHY AND DIABETES MELLITUS	0.0344828	1.72414
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.0344828	1.72414
MYOTILINOPATHY	0.0344828	1.72414
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0344828	1.72414
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.0344828	1.72414
MYOPATHY, SCAPULOHUMEROPERONEAL	0.0344828	1.72414
COSTELLO SYNDROME; CSTLO	0.0344828	1.72414
PRIMROSE SYNDROME; PRIMS	0.034453038000000005	1.7226519000000002
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.034453038000000005	1.7226519000000002
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.03428726	1.714363
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.03397676	1.698838
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.03388148	1.6940739999999999
NIJMEGEN BREAKAGE SYNDROME	0.03388148	1.6940739999999999
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.03388148	1.6940739999999999
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.03388148	1.6940739999999999
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.03388148	1.6940739999999999
ACALVARIA	0.03388148	1.6940739999999999
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.0335738	1.67869
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.033545099999999994	1.6772549999999997
HOLOPROSENCEPHALY	0.033545099999999994	1.6772549999999997
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.033545099999999994	1.6772549999999997
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0334915	1.674575
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0334915	1.674575
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0334915	1.674575
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.0334915	1.674575
JOUBERT SYNDROME 2	0.033219637999999996	1.6609819
WARSAW BREAKAGE SYNDROME; WABS	0.033219637999999996	1.6609819
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.033219637999999996	1.6609819
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.032698578	1.6349289
PROGRESSIVE HEMIFACIAL ATROPHY	0.0322581	1.6129049999999998
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.6129049999999998
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.0322581	1.6129049999999998
NODULAR NEURONAL HETEROTOPIA	0.0322581	1.6129049999999998
DESMOID TUMOR	0.0322581	1.6129049999999998
PAGOD SYNDROME	0.0322581	1.6129049999999998
NETHERTON SYNDROME; NETH	0.0322581	1.6129049999999998
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.6129049999999998
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.0322581	1.6129049999999998
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0322581	1.6129049999999998
NEONATAL ADRENOLEUKODYSTROPHY	0.0322581	1.6129049999999998
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.6129049999999998
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0322581	1.6129049999999998
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.6129049999999998
NEUROCUTANEOUS MELANOCYTOSIS	0.0322581	1.6129049999999998
PELVIS-SHOULDER DYSPLASIA	0.0322581	1.6129049999999998
COLOBOMA, OCULAR	0.0322581	1.6129049999999998
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.0322581	1.6129049999999998
TETRASOMY 18P	0.0322581	1.6129049999999998
PAPILLORENAL SYNDROME	0.0322581	1.6129049999999998
COLOBOMA OF OPTIC NERVEOPTIC NERVE HEAD PITS, BILATERAL CONGENITAL, INCLUDED	0.0322581	1.6129049999999998
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.6129049999999998
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.6129049999999998
WOLCOTT-RALLISON SYNDROME	0.0322581	1.6129049999999998
ACRO-RENAL-OCULAR SYNDROME	0.0322581	1.6129049999999998
CURRY-JONES SYNDROME	0.0322581	1.6129049999999998
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.0322581	1.6129049999999998
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.0322581	1.6129049999999998
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.6129049999999998
RENAL COLOBOMA SYNDROME	0.0322581	1.6129049999999998
ROWLEY-ROSENBERG SYNDROME	0.0322581	1.6129049999999998
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	1.6129049999999998
MORNING GLORY DISC ANOMALY	0.0322581	1.6129049999999998
EDINBURGH MALFORMATION SYNDROME	0.0322581	1.6129049999999998
COFFIN-LOWRY SYNDROME	0.0322581	1.6129049999999998
THANATOPHORIC DYSPLASIA TYPE 2	0.0322581	1.6129049999999998
SPINOCEREBELLAR ATAXIA TYPE 34	0.0322581	1.6129049999999998
SYMMETRICAL THALAMIC CALCIFICATIONS	0.0322581	1.6129049999999998
HYDROXYKYNURENINURIA	0.0322581	1.6129049999999998
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.6129049999999998
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.0322581	1.6129049999999998
INFANTILE MYOFIBROMATOSIS	0.0322581	1.6129049999999998
LEBER CONGENITAL AMAUROSIS	0.0322581	1.6129049999999998
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.0322581	1.6129049999999998
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.0322581	1.6129049999999998
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.6129049999999998
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.6129049999999998
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.0322581	1.6129049999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.032144568	1.6072284
ROIFMAN SYNDROME	0.031228798000000002	1.5614399
ROIFMAN SYNDROME; RFMN	0.031228798000000002	1.5614399
LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3	0.03045004	1.522502
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.030302999999999997	1.5151499999999998
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.030302999999999997	1.5151499999999998
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.030302999999999997	1.5151499999999998
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.030302999999999997	1.5151499999999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.030302999999999997	1.5151499999999998
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.030302999999999997	1.5151499999999998
DISTAL NEBULIN MYOPATHY	0.030302999999999997	1.5151499999999998
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.029774938	1.4887469
AASE-SMITH SYNDROME	0.02968687	1.4843435
OLIVER SYNDROME	0.02966099	1.4830495000000001
STÜVE-WIEDEMANN SYNDROME	0.02966099	1.4830495000000001
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.029485918	1.4742959
KAPUR-TORIELLO SYNDROME	0.029304840000000002	1.4652420000000002
EMANUEL SYNDROME	0.029101458	1.4550729
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.029101458	1.4550729
BRUCK SYNDROME 2	0.02895166	1.447583
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.028618680000000004	1.4309340000000002
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.028155580000000003	1.4077790000000001
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.02806349	1.4031745
SECKEL SYNDROME 1; SCKL1	0.027925980000000003	1.3962990000000002
DISTAL MONOSOMY 12Q	0.027862538	1.3931269
BAND HETEROTOPIA; BH	0.02779647	1.3898235
PMM2-CDG	0.02710195	1.3550975
MICROHYDRANENCEPHALY; MHAC	0.02710195	1.3550975
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.027101838000000003	1.3550919000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.027062148	1.3531074
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.02685292	1.342646
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.02685292	1.342646
TETRASOMY 9P	0.025883008	1.2941504
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.025814838	1.2907419
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.025814838	1.2907419
CHROMOSOME 17P13.1 DELETION SYNDROME	0.025814838	1.2907419
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.025595220000000002	1.2797610000000001
TRISOMY 8P	0.025504338	1.2752169
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.025504338	1.2752169
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.024853300000000002	1.2426650000000001
SLC39A8-CDG	0.024853300000000002	1.2426650000000001
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.024853300000000002	1.2426650000000001
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.024659450000000003	1.2329725000000002
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.02443564	1.2217820000000001
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.024333988	1.2166994
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.024217338	1.2108669
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.024217338	1.2108669
CLASSIC MULTIMINICORE MYOPATHY	0.024217338	1.2108669
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.02413986	1.206993
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.023672978000000004	1.1836489000000001
611961 STEVENSON-CAREY SYNDROME	0.023647210000000002	1.1823605000000001
JOUBERT SYNDROME WITH OCULAR DEFECT	0.023372450000000003	1.1686225000000001
JOUBERT SYNDROME WITH RENAL DEFECT	0.023372450000000003	1.1686225000000001
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.0232558	1.16279
AICARDI-GOUTIÈRES SYNDROME	0.0232558	1.16279
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.0232558	1.16279
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.0232558	1.16279
BATHING SUIT ICHTHYOSIS	0.0232558	1.16279
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0232558	1.16279
DISTAL MYOTILINOPATHY	0.0232558	1.16279
CENTRAL CORE DISEASE	0.0232558	1.16279
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.0232558	1.16279
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.0232558	1.16279
ANE SYNDROME	0.0232558	1.16279
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.0232558	1.16279
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.0232558	1.16279
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.02297192	1.148596
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.022861678	1.1430839
MEIER-GORLIN SYNDROME 1; MGORS1	0.022711440000000003	1.1355720000000002
FRYNS SYNDROME; FRNS	0.022711440000000003	1.1355720000000002
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.022710608	1.1355304
LISSENCEPHALY 3; LIS3	0.022710608	1.1355304
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.02245668	1.1228339999999999
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.02240138	1.120069
WEAVER SYNDROME	0.022049598000000004	1.1024799
RECOMBINANT CHROMOSOME 8 SYNDROME	0.022049598000000004	1.1024799
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.022049598000000004	1.1024799
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.022049598000000004	1.1024799
MOSAIC TRISOMY 15	0.02204909	1.1024545000000001
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.02184876	1.092438
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.021794838	1.0897419
MYOPATHY, CENTRONUCLEAR, 5	0.021794838	1.0897419
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.021794838	1.0897419
JOUBERT SYNDROME	0.021749070000000002	1.0874535
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.021424440000000003	1.0712220000000001
RENPENNING SYNDROME 1; RENS1	0.021424440000000003	1.0712220000000001
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.021088060000000002	1.0544030000000002
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.021088060000000002	1.0544030000000002
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.021088060000000002	1.0544030000000002
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.0208333	1.041665
PROTRUSIO ACETABULI	0.0208333	1.041665
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.020813978	1.0406989
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.020800588000000002	1.0400294
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.020762598000000004	1.0381299000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.020551558	1.0275779
MICROPHTHALMIA, SYNDROMIC 4	0.02049128	1.024564
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.02049128	1.024564
MEGAEPIPHYSEAL DWARFISM	0.02049128	1.024564
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0201549	1.007745
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.01996896	0.998448
NEU-LAXOVA SYNDROME	0.01996896	0.998448
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.01996896	0.998448
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.019943348	0.9971673999999999
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.01991758	0.9958790000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.019852440000000002	0.9926220000000001
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.01983905	0.9919525
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.019801060000000002	0.9900530000000001
BRACHYDACTYLY, TYPE B1	0.019801060000000002	0.9900530000000001
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.019801060000000002	0.9900530000000001
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.019801060000000002	0.9900530000000001
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.019801060000000002	0.9900530000000001
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.019801060000000002	0.9900530000000001
FRONTONASAL DYSPLASIA 1; FND1	0.019801060000000002	0.9900530000000001
311450 PALLISTER W SYNDROME;;W SYNDROME	0.019801060000000002	0.9900530000000001
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.019801060000000002	0.9900530000000001
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.019801060000000002	0.9900530000000001
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.019801060000000002	0.9900530000000001
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.019801060000000002	0.9900530000000001
HUNTER-MACDONALD SYNDROME	0.019801060000000002	0.9900530000000001
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.019801060000000002	0.9900530000000001
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.019801060000000002	0.9900530000000001
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.019801060000000002	0.9900530000000001
SCHAAF-YANG SYNDROME; SHFYNG	0.01972246	0.9861230000000001
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.01959002	0.979501
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.01933796	0.966898
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.01933796	0.966898
ATELOSTEOGENESIS TYPE II	0.01933796	0.966898
TARP SYNDROME; TARPS	0.019251568000000004	0.9625784000000002
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.019144788000000003	0.9572394000000002
VICI SYNDROME; VICIS	0.019002538000000003	0.9501269000000001
FONTAINE PROGEROID SYNDROME; FPS	0.018915188000000003	0.9457594000000001
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.01886941	0.9434705
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.943395
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.943395
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.943395
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.943395
MONOPHALANGY OF GREAT TOE	0.0188679	0.943395
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.943395
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.943395
RAYNAUD DISEASE	0.0188679	0.943395
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.943395
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.943395
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.943395
TRACHEOBRONCHOMEGALY	0.0188679	0.943395
CARPAL DISPLACEMENT	0.0188679	0.943395
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.943395
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.943395
PUBIC BONE DYSPLASIA	0.0188679	0.943395
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.943395
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.943395
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.943395
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.943395
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.943395
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.943395
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.943395
HHHH SYNDROME	0.0188679	0.943395
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.943395
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.943395
TOE, MISSHAPEN	0.0188679	0.943395
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0188679	0.943395
KNUCKLE PADS	0.0188679	0.943395
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.943395
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.943395
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.943395
VESICOURETERAL REFLUX 1	0.0188679	0.943395
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.943395
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.943395
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.943395
SPINAL ARACHNOIDITIS	0.0188679	0.943395
VAN DEN BOSCH SYNDROME	0.0188679	0.943395
THROMBOCYTOPENIA 3	0.0188679	0.943395
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.943395
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.0188679	0.943395
NEPHROSIALIDOSIS	0.0188679	0.943395
LETTERER-SIWE DISEASE	0.0188679	0.943395
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01886478	0.943239
LOWE OCULOCEREBRORENAL SYNDROME	0.01875289	0.9376445000000001
ENDOCARDIAL FIBROELASTOSIS	0.0185284	0.92642
STROMME SYNDROME; STROMS	0.018290030000000002	0.9145015000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.017834618	0.8917309
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.017616279999999998	0.8808139999999999
FIBROSCLEROSIS, MULTIFOCAL	0.01746589	0.8732945000000001
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.01746589	0.8732945000000001
SYNDACTYLY, TYPE V	0.01746589	0.8732945000000001
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.017290818	0.8645409
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.86207
SICKLE CELL ANEMIA	0.0172414	0.86207
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.86207
TRANSSEXUALITY	0.0172414	0.86207
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.86207
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.86207
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.86207
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.86207
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.86207
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.86207
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.86207
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.86207
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.86207
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.86207
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.86207
DIASTEMATOMYELIA	0.0172414	0.86207
MOTION SICKNESS	0.0172414	0.86207
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.86207
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.86207
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.86207
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.86207
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.86207
CERVICAL RIB	0.0172414	0.86207
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.86207
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.86207
JUMPING FRENCHMAN OF MAINE	0.0172414	0.86207
CARDIAC ARRHYTHMIA	0.0172414	0.86207
269800 SENILE PLAQUE FORMATION	0.0172414	0.86207
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.86207
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.86207
PALMOMENTAL REFLEX	0.0172414	0.86207
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.86207
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.86207
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.86207
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.86207
ALCOHOL DEPENDENCE	0.0172414	0.86207
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.86207
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.86207
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.86207
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.86207
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.86207
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.86207
RHEUMATOID ARTHRITIS	0.0172414	0.86207
MYOPATHY, CONGENITAL	0.0172414	0.86207
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.86207
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.86207
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.86207
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.016954438	0.8477218999999999
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.016954438	0.8477218999999999
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.016954438	0.8477218999999999
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.01691886	0.845943
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.01675656	0.837828
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.016692418000000004	0.8346209000000002
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.01666665	0.8333325
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.01666665	0.8333325
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.016329279999999998	0.8164639999999999
HARDIKAR SYNDROME	0.016329279999999998	0.8164639999999999
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.01612281	0.8061405
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.01612281	0.8061405
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.015992899999999997	0.7996449999999998
PSEUDOAMINOPTERIN SYNDROME	0.015992899999999997	0.7996449999999998
MARDEN-WALKER SYNDROME	0.01584808	0.792404
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.015667438	0.7833718999999999
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.015667438	0.7833718999999999
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.015667438	0.7833718999999999
POTOCKI-LUPSKI SYNDROME	0.015667438	0.7833718999999999
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.015667438	0.7833718999999999
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.015667438	0.7833718999999999
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.015667438	0.7833718999999999
TIMOTHY SYNDROME; TS	0.015667438	0.7833718999999999
NATIVE AMERICAN MYOPATHY	0.015624100000000002	0.7812050000000001
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.015624100000000002	0.7812050000000001
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.015568580000000002	0.7784290000000001
TIBIAL HEMIMELIA	0.015568580000000002	0.7784290000000001
8Q21.11 MICRODELETION SYNDROME	0.01552865	0.7764325
OROFACIODIGITAL SYNDROME VI	0.015405418000000002	0.7702709000000001
BRANCHIOOCULOFACIAL SYNDROME	0.015105480000000001	0.755274
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.015069038000000002	0.7534519000000001
PSEUDOTRISOMY 13 SYNDROME	0.015023258	0.7511629
MOSAIC TRISOMY 8	0.01491231	0.7456155
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.01491231	0.7456155
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.01491231	0.7456155
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0147059	0.7352949999999999
TRANSKETOLASE DEFICIENCY	0.0147059	0.7352949999999999
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.0147059	0.7352949999999999
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.0147059	0.7352949999999999
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.0147059	0.7352949999999999
ADAMS-OLIVER SYNDROME 5; AOS5	0.0147059	0.7352949999999999
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.0147059	0.7352949999999999
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0147059	0.7352949999999999
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.0147059	0.7352949999999999
TRANSALDOLASE DEFICIENCY	0.0147059	0.7352949999999999
LOEYS-DIETZ SYNDROME 5	0.0147059	0.7352949999999999
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.0147059	0.7352949999999999
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0147059	0.7352949999999999
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.0147059	0.7352949999999999
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.0147059	0.7352949999999999
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0147059	0.7352949999999999
TRICUSPID ATRESIA	0.0147059	0.7352949999999999
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.014654460000000001	0.732723
CEREBROOCULONASAL SYNDROME	0.014443880000000003	0.7221940000000001
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.014443880000000003	0.7221940000000001
ZECHI-CEIDE SYNDROME	0.014443880000000003	0.7221940000000001
ZECHI-CEIDE SYNDROME	0.014443880000000003	0.7221940000000001
CEREBROFACIOTHORACIC DYSPLASIA	0.014443880000000003	0.7221940000000001
MOEBIUS SYNDROME; MBS	0.0143371	0.716855
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.0143371	0.716855
JACOBSEN SYNDROME	0.01431808	0.715904
WARBURG MICRO SYNDROME 2; WARBM2	0.014313929999999999	0.7156965
3P25.3 MICRODELETION SYNDROME	0.014281580000000002	0.7140790000000001
HEREDITARY ACROKERATOTIC POIKILODERMA	0.01424165	0.7120825
MICRO SYNDROME	0.014107500000000002	0.7053750000000001
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.014107500000000002	0.7053750000000001
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.014107500000000002	0.7053750000000001
DE BARSY SYNDROME	0.014107500000000002	0.7053750000000001
WALKER-WARBURG SYNDROME	0.01406172	0.703086
OCULOCEREBROCUTANEOUS SYNDROME	0.01406172	0.703086
IMMUNODEFICIENCY 23; IMD23	0.013992618	0.6996309000000001
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.013945200000000001	0.6972600000000001
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.013945200000000001	0.6972600000000001
JOUBERT SYNDROME 6	0.013782038000000002	0.6891019
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.013782038000000002	0.6891019
COACH SYNDROME	0.013782038000000002	0.6891019
JOUBERT SYNDROME 35; JBTS35	0.013782038000000002	0.6891019
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.013782038000000002	0.6891019
JOUBERT SYNDROME 3; JBTS3	0.013782038000000002	0.6891019
JOUBERT SYNDROME 4	0.013782038000000002	0.6891019
COG1-CDG	0.013782038000000002	0.6891019
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.013782038000000002	0.6891019
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.013782038000000002	0.6891019
PSEUDO-TORCH SYNDROME 2	0.013736258000000001	0.6868129000000001
ADAMS-OLIVER SYNDROME 2; AOS2	0.013736258000000001	0.6868129000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.013736258000000001	0.6868129000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.013736258000000001	0.6868129000000001
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.013736258000000001	0.6868129000000001
JOUBERT SYNDROME 24	0.013736258000000001	0.6868129000000001
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.013736258	0.6868129
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.013619738000000001	0.6809869000000001
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.013619738000000001	0.6809869000000001
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.013619738000000001	0.6809869000000001
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.013619738000000001	0.6809869000000001
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.013619738000000001	0.6809869000000001
OCULOSKELETODENTAL SYNDROME; OCSKD	0.0134821	0.6741050000000001
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.013305878	0.6652939
KOOLEN-DE VRIES SYNDROME; KDVS	0.013305878	0.6652939
GERMAN SYNDROME	0.013288930000000001	0.6644465
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.013237548	0.6618774
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.013237548	0.6618774
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.013237548	0.6618774
2P15P16.1 MICRODELETION SYNDROME	0.013212498	0.6606249
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.013156638	0.6578319
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.013156638	0.6578319
WISKOTT-ALDRICH SYNDROME	0.01303108	0.651554
NETHERTON SYNDROME	0.01303108	0.651554
CUTIS LAXA	0.01303108	0.651554
IMMUNODEFICIENCY 50; IMD50	0.01303108	0.651554
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.01303108	0.651554
CHRONIC GRANULOMATOUS DISEASE	0.01303108	0.651554
WARBURG MICRO SYNDROME 3; WARBM3	0.013026929999999999	0.6513464999999999
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.012963467999999999	0.6481733999999999
NEMALINE MYOPATHY 2; NEM2	0.01291598	0.645799
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.012820500000000002	0.6410250000000001
AMISH LETHAL MICROCEPHALY	0.012820500000000002	0.6410250000000001
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.012820500000000002	0.6410250000000001
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.012820500000000002	0.6410250000000001
JOUBERT SYNDROME 13; JBTS13	0.012820500000000002	0.6410250000000001
JOUBERT SYNDROME 17; JBTS17	0.012820500000000002	0.6410250000000001
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.012820500000000002	0.6410250000000001
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.012820500000000002	0.6410250000000001
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.012820500000000002	0.6410250000000001
JOUBERT SYNDROME 10	0.012820500000000002	0.6410250000000001
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.012820500000000002	0.6410250000000001
ANTERIOR SEGMENT DYSGENESIS 3	0.012820500000000002	0.6410250000000001
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.012820500000000002	0.6410250000000001
LEBER CONGENITAL AMAUROSIS, TYPE II	0.012820500000000002	0.6410250000000001
FRONTONASAL DYSPLASIA 2; FND2	0.012820500000000002	0.6410250000000001
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.012820500000000002	0.6410250000000001
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.012820500000000002	0.6410250000000001
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.012820500000000002	0.6410250000000001
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.01277472	0.638736
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.01277472	0.638736
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.01277472	0.638736
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.01277472	0.638736
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.012658200000000001	0.6329100000000001
CONGENITAL PATELLA DISLOCATION	0.012658200000000001	0.6329100000000001
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.012658200000000001	0.6329100000000001
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.012658200000000001	0.6329100000000001
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.012658200000000001	0.6329100000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.012658200000000001	0.6329100000000001
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.012658200000000001	0.6329100000000001
OTOONYCHOPERONEAL SYNDROME	0.012658200000000001	0.6329100000000001
MYOPATHY, DISTAL 3	0.012658200000000001	0.6329100000000001
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.012658200000000001	0.6329100000000001
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.012658200000000001	0.6329100000000001
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.012658200000000001	0.6329100000000001
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.012658200000000001	0.6329100000000001
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.012202758000000001	0.6101379
RUIJS-AALFS SYNDROME; RJALS	0.0121951	0.609755
ACRORENAL-MANDIBULAR SYNDROME	0.0121951	0.609755
PELVISCAPULAR DYSPLASIA	0.0121951	0.609755
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0121951	0.609755
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.0121951	0.609755
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.0121951	0.609755
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.0121951	0.609755
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.0121951	0.609755
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.0121951	0.609755
13Q12.3 MICRODELETION SYNDROME	0.01202698	0.601349
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.012001930000000001	0.6000965
COFS SYNDROME	0.012001930000000001	0.6000965
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.012001928	0.6000964
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.011950548	0.5975274
DUBOWITZ SYNDROME	0.011682498	0.5841249
TRISOMY 1Q	0.01156422	0.578211
ADAMS-OLIVER SYNDROME 1; AOS1	0.011513488	0.5756744
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.011513488	0.5756744
DIAPHANOSPONDYLODYSOSTOSIS	0.011513488	0.5756744
DIASTROPHIC DWARFISM	0.01131519	0.5657595
METATROPIC DYSPLASIA	0.0112926	0.56463
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.01124122	0.562061
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.011177108	0.5588554
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.01105734	0.552867
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.01105734	0.552867
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.01105734	0.552867
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.01104039	0.5520195
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.01104039	0.5520195
MECKEL SYNDROME 12; MKS12	0.01104039	0.5520195
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.01104039	0.5520195
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.011014778	0.5507388999999999
PEHO SYNDROME	0.01079136	0.539568
CONGENITAL MYASTHENIC SYNDROME	0.01079136	0.539568
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.01079136	0.539568
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.01072096	0.536048
DUBOWITZ SYNDROME	0.01072096	0.536048
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01072096	0.536048
XQ12-Q13.3 DUPLICATION SYNDROME	0.01072096	0.536048
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.01072096	0.536048
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.01072096	0.536048
DISTAL TRISOMY 5Q	0.01072096	0.536048
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.01072096	0.536048
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.01072096	0.536048
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.01072096	0.536048
DOORS SYNDROME	0.010551950000000001	0.5275975
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.010551950000000001	0.5275975
ZTTK SYNDROME; ZTTKS	0.010529428	0.5264714
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.010395498	0.5197748999999999
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.010395498	0.5197748999999999
SULFOCYSTEINURIA	0.010395498	0.5197748999999999
SHWACHMAN-DIAMOND SYNDROME	0.010395498	0.5197748999999999
COFFIN-SIRIS SYNDROME 8; CSS8	0.010395498	0.5197748999999999
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.010395498	0.5197748999999999
OTOPALATODIGITAL SYNDROME TYPE 2	0.01027722	0.513861
ZELLWEGER SYNDROME	0.01021557	0.5107785
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.01021557	0.5107785
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.01021557	0.5107785
MENTAL RETARDATION, X-LINKED 103	0.01021557	0.5107785
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.010193048	0.5096524
19P13.12 MICRODELETION SYNDROME	0.01010462	0.505231
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.01010462	0.505231
CATEL-MANZKE SYNDROME; CATMANS	0.01005324	0.5026619999999999
MYHRE SYNDROME	0.01005324	0.5026619999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.01005324	0.5026619999999999
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.01005324	0.5026619999999999
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.01005324	0.5026619999999999
AYMÉ-GRIPP SYNDROME	0.01005324	0.5026619999999999
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.01002819	0.5014095
JACOBSEN SYNDROME	0.009944017999999999	0.49720089999999995
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.009944017999999999	0.49720089999999995
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.009944017999999999	0.49720089999999995
CK SYNDROME	0.009890108	0.4945054
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.009890108	0.4945054
PEHO SYNDROME; PEHO	0.009890108	0.4945054
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.009890108	0.4945054
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.009890108	0.4945054
GOLDBERG-SHPRINTZEN SYNDROME	0.009890108	0.4945054
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.009890108	0.4945054
JOUBERT SYNDROME 32; JBTS32	0.009890108	0.4945054
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.009890108	0.4945054
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.009890108	0.4945054
FUMARASE DEFICIENCY; FMRD	0.009890108	0.4945054
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.009890108	0.4945054
ADDUCTED THUMBS SYNDROME	0.009779158	0.4889579
BOHRING-OPITZ SYNDROME	0.009727778	0.48638889999999996
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00969181	0.48459050000000004
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.00969181	0.48459050000000004
CHROMOSOME 18Q DELETION SYNDROME	0.009691808	0.4845904
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.009567889999999999	0.47839449999999994
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.009442778	0.47213890000000003
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.009442778	0.47213890000000003
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.00943396	0.471698
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00943396	0.471698
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00943396	0.471698
BAZEX SYNDROME; BZX	0.00943396	0.471698
AUTOSOMAL ERYTHROPOIETIC PROTOPORPHYRIA	0.00943396	0.471698
ACRAL PEELING SKIN SYNDROME	0.00943396	0.471698
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.00943396	0.471698
CLASSIC PHENYLKETONURIA	0.00943396	0.471698
ECTODERMAL DYSPLASIA SYNDROME	0.00943396	0.471698
NEUTROPHIL CHEMOTACTIC RESPONSE	0.00943396	0.471698
PORPHYRIA CUTANEA TARDA, TYPE I	0.00943396	0.471698
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00943396	0.471698
EPIDERMOLYTIC PALMOPLANTAR KERATODERMA	0.00943396	0.471698
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.00943396	0.471698
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00943396	0.471698
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00943396	0.471698
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00943396	0.471698
PROPIONIC ACIDEMIA	0.00943396	0.471698
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.00943396	0.471698
IMMUNODEFICIENCY 55; IMD55	0.00943396	0.471698
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00943396	0.471698
MYCOSIS FUNGOIDES	0.00943396	0.471698
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00943396	0.471698
BULLOUS PEMPHIGOID	0.00943396	0.471698
2Q37 MICRODELETION SYNDROME	0.00943396	0.471698
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.00943396	0.471698
CHROMOSOME 2Q37 DELETION SYNDROME	0.00943396	0.471698
CLASSICAL EHLERS-DANLOS SYNDROME	0.00943396	0.471698
IGE RESPONSIVENESS, ATOPIC	0.00943396	0.471698
CASPASE 8 DEFICIENCY	0.00943396	0.471698
PELGER-HUET ANOMALY; PHA	0.00943396	0.471698
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00943396	0.471698
DERMATITIS, ATOPIC	0.00943396	0.471698
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00943396	0.471698
PHENYLKETONURIA	0.00943396	0.471698
PITYRIASIS RUBRA PILARIS	0.00943396	0.471698
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00943396	0.471698
DERMATITIS HERPETIFORMIS	0.00943396	0.471698
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.00943396	0.471698
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.00943396	0.471698
CLASSIC MYCOSIS FUNGOIDES	0.00943396	0.471698
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.00943396	0.471698
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.00943396	0.471698
PROTOPORPHYRIA, ERYTHROPOIETIC	0.00943396	0.471698
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00943396	0.471698
ELASTODERMA	0.00943396	0.471698
CRANIO-OSTEOARTHROPATHY	0.00943396	0.471698
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.009391398	0.46956990000000004
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.009391398	0.46956990000000004
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.00892857	0.4464285
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00892857	0.4464285
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.00892857	0.4464285
ANIRIDIA	0.00892857	0.4464285
CEDNIK SYNDROME	0.00892857	0.4464285
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.00892857	0.4464285
LHERMITTE-DUCLOS DISEASE	0.00892857	0.4464285
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00892857	0.4464285
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.00892857	0.4464285
DESMOSTEROLOSIS	0.00892857	0.4464285
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00892857	0.4464285
CURRY-JONES SYNDROME	0.00892857	0.4464285
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.00892857	0.4464285
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.00892857	0.4464285
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.00892857	0.4464285
LISSENCEPHALY 8; LIS8	0.00892857	0.4464285
KNOBLOCH SYNDROME 1; KNO1	0.00892857	0.4464285
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.00892857	0.4464285
PEHO-LIKE SYNDROME; PEHOL	0.00892857	0.4464285
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.00892857	0.4464285
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.00892857	0.4464285
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.00892857	0.4464285
WILLIAMS-BEUREN SYNDROME; WBS	0.008906048	0.4453024
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.008906048	0.4453024
MOEBIUS SYNDROME	0.00881762	0.440881
RAINE SYNDROME	0.00881762	0.440881
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.00881762	0.440881
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.00881762	0.440881
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00881762	0.440881
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.00881762	0.440881
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.00876624	0.438312
GLASS SYNDROME	0.00876624	0.438312
TEEBI-SHALTOUT SYNDROME; TBSH	0.00876624	0.438312
OROFACIODIGITAL SYNDROME IX; OFD9	0.00876624	0.438312
DUANE RETRACTION SYNDROME	0.00876624	0.438312
BRITTLE CORNEA SYNDROME	0.00876624	0.438312
LOEYS-DIETZ SYNDROME 3; LDS3	0.00876624	0.438312
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.00873027	0.4365135
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.008657017999999999	0.4328508999999999
ROTHMUND-THOMSON SYNDROME	0.008481240000000001	0.42406200000000005
COCKAYNE SYNDROME	0.008481240000000001	0.42406200000000005
NOONAN SYNDROME 2; NS2	0.008481240000000001	0.42406200000000005
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.008481240000000001	0.42406200000000005
1Q21.1 MICRODUPLICATION SYNDROME	0.008481240000000001	0.42406200000000005
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00842986	0.42149300000000006
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00842986	0.42149300000000006
GM1 GANGLIOSIDOSIS	0.00840481	0.4202405
HENNEKAM SYNDROME	0.00840481	0.4202405
OROFACIODIGITAL SYNDROME TYPE 4	0.00840481	0.4202405
HURLER SYNDROME	0.00840481	0.4202405
NEMALINE MYOPATHY 10	0.008155778	0.4077889
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.008155778	0.4077889
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.008155778	0.4077889
MULTIMINICORE MYOPATHY	0.008155778	0.4077889
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.008155778	0.4077889
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.008155778	0.4077889
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.008155778	0.4077889
GLYCOGEN STORAGE DISEASE IV	0.008155778	0.4077889
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.008155778	0.4077889
COHEN-GIBSON SYNDROME; COGIS	0.008104398	0.4052199
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.008104398	0.4052199
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.008104398	0.4052199
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.008104398	0.4052199
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.008104398	0.4052199
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.008104398	0.4052199
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.008104398	0.4052199
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.007970277999999999	0.3985139
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00794451	0.3972255
MECKEL SYNDROME 13; MKS13	0.00794451	0.3972255
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00794451	0.3972255
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00794451	0.3972255
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.00794451	0.3972255
TRISOMY 8Q	0.00771807	0.38590349999999995
MOSAIC TRISOMY 9	0.00771807	0.38590349999999995
ACROCARDIOFACIAL SYNDROME	0.00771807	0.38590349999999995
MOWAT-WILSON SYNDROME	0.00771807	0.38590349999999995
AARSKOG-SCOTT SYNDROME	0.00771807	0.38590349999999995
RECOMBINANT 8 SYNDROME	0.00771807	0.38590349999999995
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00771807	0.38590349999999995
TRISOMY 18	0.00771807	0.38590349999999995
FRONTONASAL DYSPLASIA	0.00771807	0.38590349999999995
MOSAIC TRISOMY 14	0.00771807	0.38590349999999995
SIMPSON-GOLABI-BEHMEL SYNDROME	0.00771807	0.38590349999999995
GORDON SYNDROME	0.00771807	0.38590349999999995
TARP SYNDROME	0.007718068	0.3859034
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.007718068	0.3859034
HURLER SYNDROME	0.007695479999999999	0.38477399999999995
GAUCHER DISEASE TYPE 2	0.007695479999999999	0.38477399999999995
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.007695479999999999	0.38477399999999995
EMANUEL SYNDROME	0.007469038000000001	0.37345190000000006
VICI SYNDROME	0.00744327	0.3721635
JUNG SYNDROME	0.00744327	0.3721635
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.00744327	0.3721635
TETRASOMY 5P	0.00744327	0.3721635
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00719424	0.35971200000000003
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.00719424	0.35971200000000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00719424	0.35971200000000003
GAUCHER DISEASE, PERINATAL LETHAL	0.00719424	0.35971200000000003
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00719424	0.35971200000000003
RFT1-CDG	0.00719424	0.35971200000000003
INIENCEPHALY	0.00719424	0.35971200000000003
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00719424	0.35971200000000003
INTERMEDIATE NEMALINE MYOPATHY	0.00719424	0.35971200000000003
TYPICAL NEMALINE MYOPATHY	0.00719424	0.35971200000000003
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00719424	0.35971200000000003
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00719424	0.35971200000000003
ARTHROGRYPOSIS - HYPERKERATOSIS, LETHAL FORM	0.00719424	0.35971200000000003
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00719424	0.35971200000000003
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00719424	0.35971200000000003
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00719424	0.35971200000000003
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00719424	0.35971200000000003
RETT SYNDROME	0.00719424	0.35971200000000003
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.00719424	0.35971200000000003
PELVIC DYSPLASIA - ARTHROGRYPOSIS OF LOWER LIMBS	0.00719424	0.35971200000000003
GAUCHER DISEASE	0.00719424	0.35971200000000003
GERMAN SYNDROME	0.00719424	0.35971200000000003
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00719424	0.35971200000000003
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.00719424	0.35971200000000003
CHRISTIANSON SYNDROME	0.00719424	0.35971200000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.00719424	0.35971200000000003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.00719424	0.35971200000000003
NAKAJO-NISHIMURA SYNDROME	0.00719424	0.35971200000000003
NEMALINE MYOPATHY 3; NEM3	0.00719424	0.35971200000000003
FETAL GAUCHER DISEASE	0.00719424	0.35971200000000003
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.00719424	0.35971200000000003
SPONDYLOSPINAL THORACIC DYSOSTOSIS	0.00719424	0.35971200000000003
BRUCK SYNDROME	0.00719424	0.35971200000000003
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.00719424	0.35971200000000003
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.00719424	0.35971200000000003
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00719424	0.35971200000000003
H SYNDROME	0.00714286	0.357143
RAHMAN SYNDROME	0.00714286	0.357143
PSEUDODIASTROPHIC DYSPLASIA	0.00714286	0.357143
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.00714286	0.357143
20Q11.2 MICRODELETION SYNDROME	0.00714286	0.357143
SILLENCE SYNDROME	0.00714286	0.357143
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00714286	0.357143
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.00714286	0.357143
MEESTER-LOEYS SYNDROME; MRLS	0.00714286	0.357143
MEIER-GORLIN SYNDROME 2; MGORS2	0.00714286	0.357143
W SYNDROME	0.00714286	0.357143
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.00714286	0.357143
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00714286	0.357143
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.00714286	0.357143
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00714286	0.357143
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00714286	0.357143
WAHAB SYNDROME	0.00714286	0.357143
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00714286	0.357143
GERODERMA OSTEODYSPLASTICUM; GO	0.00714286	0.357143
AYME-GRIPP SYNDROME; AYGRP	0.00714286	0.357143
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.00714286	0.357143
SCHINZEL-GIEDION SYNDROME	0.00714286	0.357143
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00714286	0.357143
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.00714286	0.357143
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00714286	0.357143
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.00714286	0.357143
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00714286	0.357143
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.007008739999999999	0.350437
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.007008739999999999	0.350437
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.007008739999999999	0.350437
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00675653	0.33782650000000003
DISTAL TRISOMY 17Q	0.00675653	0.33782650000000003
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00675653	0.33782650000000003
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00675653	0.33782650000000003
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00675653	0.33782650000000003
MECKEL SYNDROME, TYPE 1; MKS1	0.00675653	0.33782650000000003
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.006683278	0.3341639
49,XXXXY SYNDROME	0.0065075	0.325375
COFFIN-SIRIS SYNDROME 1; CSS1	0.0065075	0.325375
MEIER-GORLIN SYNDROME 6; MGORS6	0.0065075	0.325375
48,XXYY SYNDROME	0.0065075	0.325375
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0065075	0.325375
WOLF-HIRSCHHORN SYNDROME	0.0065075	0.325375
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.0065075	0.325375
COFFIN-SIRIS SYNDROME	0.0065075	0.325375
48,XXXY SYNDROME	0.0065075	0.325375
2Q24 MICRODELETION SYNDROME	0.00643107	0.3215535
BOHRING-OPITZ SYNDROME	0.00643107	0.3215535
MESOMELIC LIMB SHORTENING AND BOWING	0.00643107	0.3215535
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00643107	0.3215535
CATEL-MANZKE SYNDROME	0.00643107	0.3215535
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00643107	0.3215535
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00643107	0.3215535
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00643107	0.3215535
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.00643107	0.3215535
6Q25 MICRODELETION SYNDROME	0.00643107	0.3215535
FAMILIAL VISCERAL MYOPATHY	0.00643107	0.3215535
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00643107	0.3215535
METATROPIC DYSPLASIA	0.00643107	0.3215535
FRONTORHINY	0.00643107	0.3215535
ACROPECTOROVERTEBRAL DYSPLASIA	0.00643107	0.3215535
PELVIS-SHOULDER DYSPLASIA	0.00643107	0.3215535
OCULODENTODIGITAL DYSPLASIA	0.00643107	0.3215535
FIBROCHONDROGENESIS	0.00643107	0.3215535
ANTLEY-BIXLER SYNDROME	0.00643107	0.3215535
JOUBERT SYNDROME 26	0.006431068	0.3215534
TEMPLE SYNDROME	0.006346898	0.3173449
PALLISTER-KILLIAN SYNDROME	0.006346898	0.3173449
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.006346898	0.3173449
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.006346898	0.3173449
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.006346898	0.3173449
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.006346898	0.3173449
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00609469	0.3047345
SHPRINTZEN-GOLDBERG SYNDROME	0.00609469	0.3047345
BOWEN-CONRADI SYNDROME	0.00609469	0.3047345
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.00609469	0.3047345
ULNAR-MAMMARY SYNDROME	0.00609469	0.3047345
WEAVER SYNDROME	0.00609469	0.3047345
EAR-PATELLA-SHORT STATURE SYNDROME	0.00609469	0.3047345
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00609469	0.3047345
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.00609469	0.3047345
COG5-CDG	0.00609469	0.3047345
DISTAL TRISOMY 18Q	0.00609469	0.3047345
8Q22.1 MICRODELETION SYNDROME	0.00609469	0.3047345
DISTAL TRISOMY 15Q	0.00609469	0.3047345
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00609469	0.3047345
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00609469	0.3047345
FREEMAN-SHELDON SYNDROME	0.00609469	0.3047345
1P36 DELETION SYNDROME	0.00609469	0.3047345
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.00609469	0.3047345
TRISOMY 4P	0.00609469	0.3047345
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00609469	0.3047345
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00609469	0.3047345
TRISOMY 20P	0.00609469	0.3047345
7Q11.23 MICRODUPLICATION SYNDROME	0.006094688	0.3047344
YUNIS-VARON SYNDROME	0.006094687999999999	0.30473439999999996
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.006094687999999999	0.30473439999999996
WARBURG MICRO SYNDROME 1	0.006094687999999999	0.30473439999999996
PRADER-WILLI SYNDROME; PWS	0.005845658	0.2922829
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.005845658	0.2922829
KLEEFSTRA SYNDROME	0.005845658	0.2922829
HEART AND BRAIN MALFORMATION SYNDROME	0.0057692279999999995	0.2884614
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.0057217399999999995	0.286087
AASE-SMITH SYNDROME I	0.0057217399999999995	0.286087
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.0057217399999999995	0.286087
TRISOMY 17P	0.0057217399999999995	0.286087
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.0057217399999999995	0.286087
SWEENEY-COX SYNDROME; SWCOS	0.00546953	0.2734765
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00546953	0.2734765
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00538536	0.269268
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00538536	0.269268
PRADER-WILLI-LIKE SYNDROME	0.00538536	0.269268
16P13.2 MICRODELETION SYNDROME	0.00538536	0.269268
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00538536	0.269268
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00538536	0.269268
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00538536	0.269268
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00538536	0.269268
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.00538536	0.269268
ACROOSTEOLYSIS DOMINANT TYPE	0.0052205	0.261025
ESOPHAGEAL ATRESIA	0.0052205	0.261025
CLEIDOCRANIAL DYSPLASIA	0.0052205	0.261025
PRIMARY PULMONARY HYPOPLASIA	0.0052205	0.261025
MELNICK-NEEDLES SYNDROME	0.0052205	0.261025
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.0052205	0.261025
STICKLER SYNDROME	0.0052205	0.261025
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.0051331499999999995	0.2566575
KID SYNDROME	0.0051331499999999995	0.2566575
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.0051331499999999995	0.2566575
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0051331499999999995	0.2566575
HALLERMANN-STREIFF SYNDROME	0.0051331499999999995	0.2566575
YUNIS-VARON SYNDROME	0.0051331499999999995	0.2566575
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.0051331499999999995	0.2566575
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.0051331499999999995	0.2566575
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0051331499999999995	0.2566575
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.005059898	0.2529949
NEMALINE MYOPATHY 4	0.005059898	0.2529949
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.005059898	0.2529949
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.005059898	0.2529949
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.005059898	0.2529949
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.005059898	0.2529949
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.005059898	0.2529949
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.005059898	0.2529949
PETTIGREW SYNDROME	0.005059898	0.2529949
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.005059898	0.2529949
RIGID SPINE MUSCULAR DYSTROPHY 1	0.005059898	0.2529949
BETHLEM MYOPATHY 2; BTHLM2	0.005059898	0.2529949
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.005059898	0.2529949
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.005059898	0.2529949
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.005059898	0.2529949
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.005059898	0.2529949
KAGAMI-OGATA SYNDROME	0.005059898	0.2529949
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.005059898	0.2529949
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.005059898	0.2529949
GLUTAMINE DEFICIENCY, CONGENITAL	0.005059898	0.2529949
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.005059898	0.2529949
SIALIDOSIS TYPE 2	0.005059898	0.2529949
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.005059898	0.2529949
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.005059898	0.2529949
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.005059898	0.2529949
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.005059898	0.2529949
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005059898	0.2529949
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.005059898	0.2529949
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.005059898	0.2529949
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.005059898	0.2529949
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.005059898	0.2529949
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.005059898	0.2529949
ARTERIAL TORTUOSITY SYNDROME	0.005059898	0.2529949
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.005059898	0.2529949
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.005059898	0.2529949
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.005059898	0.2529949
MARINESCO-SJOGREN SYNDROME; MSS	0.005059898	0.2529949
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.005059898	0.2529949
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.005059898	0.2529949
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005059898	0.2529949
WILLIAMS SYNDROME	0.0048841200000000005	0.24420600000000003
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.0048841200000000005	0.24420600000000003
SANJAD-SAKATI SYNDROME	0.0048841200000000005	0.24420600000000003
OCULOCEREBRORENAL SYNDROME OF LOWE	0.0048841200000000005	0.24420600000000003
LEPRECHAUNISM	0.0048841200000000005	0.24420600000000003
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.0048841200000000005	0.24420600000000003
KLEEFSTRA SYNDROME	0.0048841200000000005	0.24420600000000003
MARTSOLF SYNDROME	0.0048841200000000005	0.24420600000000003
19Q13.11 MICRODELETION SYNDROME	0.0048841200000000005	0.24420600000000003
PRUNE BELLY SYNDROME	0.0048841200000000005	0.24420600000000003
WAARDENBURG SYNDROME TYPE 3	0.00480769	0.2403845
SPONDYLOCAMPTODACTYLY SYNDROME	0.00480769	0.2403845
ATYPICAL RETT SYNDROME	0.00480769	0.2403845
BLAU SYNDROME	0.00480769	0.2403845
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.00480769	0.2403845
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00480769	0.2403845
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.00480769	0.2403845
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00480769	0.2403845
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.00480769	0.2403845
DIGITAL EXTENSOR MUSCLE APLASIA-POLYNEUROPATHY	0.00480769	0.2403845
SPONDYLOCAMPTODACTYLY	0.00480769	0.2403845
ABLEPHARON MACROSTOMIA SYNDROME	0.00480769	0.2403845
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00480769	0.2403845
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00480769	0.2403845
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00480769	0.2403845
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00480769	0.2403845
SLC35A2-CDG	0.00480769	0.2403845
INCONTINENTIA PIGMENTI	0.00480769	0.2403845
LERI PLEONOSTEOSIS	0.00480769	0.2403845
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.00480769	0.2403845
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.00480769	0.2403845
MACDERMOT-WINTER SYNDROME	0.00480769	0.2403845
EXTENSOR TENDONS OF FINGER ANOMALIES	0.00480769	0.2403845
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00480769	0.2403845
PROXIMAL SYMPHALANGISM	0.00480769	0.2403845
DISTAL SYMPHALANGISM	0.00480769	0.2403845
MUCKLE-WELLS SYNDROME	0.00480769	0.2403845
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	0.00480769	0.2403845
ALLAN-HERNDON-DUDLEY SYNDROME	0.00480769	0.2403845
SUMMITT SYNDROME	0.00480769	0.2403845
LOEYS-DIETZ SYNDROME	0.00480769	0.2403845
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.00480769	0.2403845
KINDLER SYNDROME	0.00480769	0.2403845
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00480769	0.2403845
ENG-STROM SYNDROME	0.00480769	0.2403845
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00480769	0.2403845
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.00480769	0.2403845
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.00480769	0.2403845
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.00480769	0.2403845
INFANTILE SYSTEMIC HYALINOSIS	0.00480769	0.2403845
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.00480769	0.2403845
COOPER-JABS SYNDROME	0.00480769	0.2403845
HENNEKAM-BEEMER SYNDROME	0.00480769	0.2403845
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00480769	0.2403845
FOCAL DERMAL HYPOPLASIA	0.00480769	0.2403845
CRANIOFRONTONASAL DYSPLASIA	0.00480769	0.2403845
GALLOWAY-MOWAT SYNDROME	0.00480769	0.2403845
FLOATING-HARBOR SYNDROME	0.00480769	0.2403845
PHAVER SYNDROME	0.00480769	0.2403845
15Q24 MICRODELETION SYNDROME	0.00480769	0.2403845
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00480769	0.2403845
DIGITOTALAR DYSMORPHISM	0.00480769	0.2403845
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.00480769	0.2403845
FRONTOMETAPHYSEAL DYSPLASIA	0.00480769	0.2403845
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.00480769	0.2403845
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00480769	0.2403845
DIGITOTALAR DYSMORPHISM	0.00480769	0.2403845
ABSENCE OF FINGERPRINTS-CONGENITAL MILIA SYNDROME	0.00480769	0.2403845
CRISPONI SYNDROME	0.00480769	0.2403845
PENTASOMY X	0.00480769	0.2403845
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00480769	0.2403845
CAMPTODACTYLY 1; CAMPD1	0.00480769	0.2403845
MASA SYNDROME	0.00480769	0.2403845
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.00480769	0.2403845
DESBUQUOIS SYNDROME	0.00480769	0.2403845
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.00480769	0.2403845
HYPERTRYPTOPHANEMIA; HYPTRP	0.00480769	0.2403845
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.00480769	0.2403845
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00480769	0.2403845
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00480769	0.2403845
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00480769	0.2403845
SYNDACTYLY TYPE 2	0.00480769	0.2403845
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00480769	0.2403845
OPHTHALMOMANDIBULOMELIC DYSPLASIA	0.00480769	0.2403845
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.00480769	0.2403845
SYNDACTYLY TYPE 3	0.00480769	0.2403845
CAMPTOBRACHYDACTYLY	0.00480769	0.2403845
SYNDACTYLY TYPE 4	0.00480769	0.2403845
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00480769	0.2403845
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00480769	0.2403845
SYNDACTYLY TYPE 5	0.00480769	0.2403845
FRANK-TER HAAR SYNDROME	0.00480769	0.2403845
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.00480769	0.2403845
2P15-16.1 MICRODELETION SYNDROME	0.00480769	0.2403845
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00480769	0.2403845
15Q26 OVERGROWTH SYNDROME	0.00480769	0.2403845
MICROPHTHALMIA-MICROTIA-FETAL AKINESIA SYNDROME	0.00480769	0.2403845
16P11.2P12.2 MICRODELETION SYNDROME	0.00480769	0.2403845
CEREBELLAR HYPOPLASIA	0.004807688	0.2403844
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.004807688	0.2403844
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004807688	0.2403844
COFFIN-SIRIS SYNDROME 3; CSS3	0.004807688	0.2403844
XQ25 MICRODUPLICATION SYNDROME	0.004807688	0.2403844
COHEN SYNDROME	0.004807688	0.2403844
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.004807688	0.2403844
HOLOPROSENCEPHALY 1; HPE1	0.004807688	0.2403844
OPTIC ATROPHY 11; OPA11	0.004807688	0.2403844
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.004807688	0.2403844
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.004807688	0.2403844
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.004807688	0.2403844
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.004807688	0.2403844
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.004807688	0.2403844
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.004807688	0.2403844
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.004807688	0.2403844
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.004807688	0.2403844
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.004807688	0.2403844
XQ25 DUPLICATION SYNDROME	0.004807688	0.2403844
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.004807688	0.2403844
LISSENCEPHALY 5; LIS5	0.004807688	0.2403844
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004807688	0.2403844
MENTAL RETARDATION, X-LINKED 12; MRX12	0.004807688	0.2403844
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.004807688	0.2403844
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.004807688	0.2403844
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004807688	0.2403844
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.004807688	0.2403844
HOLOPROSENCEPHALY 2; HPE2	0.004807688	0.2403844
JOUBERT SYNDROME 25	0.004807688	0.2403844
CEREBELLAR ATAXIA, CAYMAN TYPE	0.004807688	0.2403844
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.004807688	0.2403844
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.004807688	0.2403844
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.004807688	0.2403844
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.004807688	0.2403844
EPISODIC ATAXIA, TYPE 6	0.004807688	0.2403844
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.004807688	0.2403844
HADZISELIMOVIC SYNDROME	0.004807688	0.2403844
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.004807688	0.2403844
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.004558658	0.2279329
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.004558658	0.2279329
ASPARTYLGLUCOSAMINURIA; AGU	0.004558658	0.2279329
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.004558658	0.2279329
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.004558658	0.2279329
NIEMANN-PICK DISEASE, TYPE A	0.004558658	0.2279329
HYPOPHOSPHATASIA, INFANTILE	0.004558658	0.2279329
OPSISMODYSPLASIA; OPSMD	0.004558658	0.2279329
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.004558658	0.2279329
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.004558658	0.2279329
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.004558658	0.2279329
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.004558658	0.2279329
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.004558658	0.2279329
GLYCOGEN STORAGE DISEASE II	0.004558658	0.2279329
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.004558658	0.2279329
CHITAYAT SYNDROME	0.004558658	0.2279329
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.004558658	0.2279329
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00409836	0.204918
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.00409836	0.204918
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00409836	0.204918
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.00409836	0.204918
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00409836	0.204918
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.00409836	0.204918
DRACUNCULIASIS	0.00409836	0.204918
HYPERKALEMIC PERIODIC PARALYSIS	0.00409836	0.204918
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00409836	0.204918
CUTIS LAXA-MARFANOID SYNDROME	0.00409836	0.204918
ADULT-ONSET NEMALINE MYOPATHY	0.00409836	0.204918
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.00409836	0.204918
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00409836	0.204918
HUNTINGTON DISEASE-LIKE 3	0.00409836	0.204918
LYNCH SYNDROME	0.00409836	0.204918
DUCHENNE MUSCULAR DYSTROPHY	0.00409836	0.204918
CANAVAN DISEASE	0.00409836	0.204918
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00409836	0.204918
BUSCHKE-OLLENDORFF SYNDROME	0.00409836	0.204918
CHRONIC GRAFT VERSUS HOST DISEASE	0.00409836	0.204918
CHST3-RELATED SKELETAL DYSPLASIA	0.00409836	0.204918
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00409836	0.204918
NEONATAL MARFAN SYNDROME	0.00409836	0.204918
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00409836	0.204918
MAJEED SYNDROME	0.00409836	0.204918
POTASSIUM-AGGRAVATED MYOTONIA	0.00409836	0.204918
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00409836	0.204918
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.00409836	0.204918
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.00409836	0.204918
ANAUXETIC DYSPLASIA 2; ANXD2	0.00409836	0.204918
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00409836	0.204918
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.00409836	0.204918
ICHTHYOSIS HYSTRIX OF CURTH-MACKLIN	0.00409836	0.204918
FAMILIAL COLORECTAL CANCER TYPE X	0.00409836	0.204918
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00409836	0.204918
KEPPEN-LUBINSKY SYNDROME	0.00409836	0.204918
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00409836	0.204918
ORAL SUBMUCOUS FIBROSIS	0.00409836	0.204918
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00409836	0.204918
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.00409836	0.204918
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00409836	0.204918
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00409836	0.204918
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00409836	0.204918
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00409836	0.204918
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.00409836	0.204918
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.00409836	0.204918
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00409836	0.204918
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.00409836	0.204918
SALIH MYOPATHY; SALMY	0.00409836	0.204918
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.00409836	0.204918
RESTRICTIVE DERMOPATHY, LETHAL	0.00409836	0.204918
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.00409836	0.204918
BUSCHKE-OLLENDORFF SYNDROME; BOS	0.00409836	0.204918
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.00409836	0.204918
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00409836	0.204918
CZECH DYSPLASIA, METATARSAL TYPE	0.00409836	0.204918
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.00409836	0.204918
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00409836	0.204918
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00409836	0.204918
AICARDI-GOUTIERES SYNDROME 5	0.00409836	0.204918
MARFAN SYNDROME; MFS	0.00409836	0.204918
ALLAN-HERNDON-DUDLEY SYNDROME	0.00409836	0.204918
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00409836	0.204918
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00409836	0.204918
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00409836	0.204918
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00409836	0.204918
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.00409836	0.204918
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00409836	0.204918
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00409836	0.204918
268650 RUDIGER SYNDROME	0.00409836	0.204918
STIFF SKIN SYNDROME	0.00409836	0.204918
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00409836	0.204918
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.00409836	0.204918
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00409836	0.204918
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00409836	0.204918
GROWTH FACTORS, COMBINED DEFECT OF	0.00409836	0.204918
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00409836	0.204918
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00409836	0.204918
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00409836	0.204918
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00409836	0.204918
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00409836	0.204918
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00409836	0.204918
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00409836	0.204918
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.00409836	0.204918
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00409836	0.204918
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00409836	0.204918
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.00409836	0.204918
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00409836	0.204918
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00409836	0.204918
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00409836	0.204918
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00409836	0.204918
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	0.00409836	0.204918
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00409836	0.204918
NEMALINE MYOPATHY 1; NEM1	0.00409836	0.204918
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00409836	0.204918
MAJEED SYNDROME	0.00409836	0.204918
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00409836	0.204918
MUCOPOLYSACCHARIDOSIS, TYPE II	0.00409836	0.204918
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00409836	0.204918
BASAN SYNDROME	0.00409836	0.204918
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.00409836	0.204918
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00409836	0.204918
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.0038719180000000002	0.19359590000000002
MEND SYNDROME	0.003871918	0.1935959
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.003871918	0.1935959
MOWAT-WILSON SYNDROME; MOWS	0.003871918	0.1935959
KABUKI SYNDROME 1	0.003871918	0.1935959
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.003871918	0.1935959
CRANIOFRONTONASAL SYNDROME; CFNS	0.003871918	0.1935959
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.003871918	0.1935959
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.003871918	0.1935959
ACROCALLOSAL SYNDROME; ACLS	0.003871918	0.1935959
AU-KLINE SYNDROME; AUKS	0.003871918	0.1935959
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00384615	0.1923075
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00384615	0.1923075
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.00384615	0.1923075
HOYERAAL-HREIDARSSON SYNDROME	0.00384615	0.1923075
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00384615	0.1923075
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.00384615	0.1923075
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00384615	0.1923075
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.00384615	0.1923075
LISSENCEPHALY 1; LIS1	0.00384615	0.1923075
GABA-TRANSAMINASE DEFICIENCY	0.00384615	0.1923075
PHACE ASSOCIATION	0.00384615	0.1923075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.00384615	0.1923075
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00384615	0.1923075
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.00384615	0.1923075
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.00384615	0.1923075
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00384615	0.1923075
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00384615	0.1923075
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00384615	0.1923075
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.00384615	0.1923075
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.00384615	0.1923075
MAN1B1-CDG	0.00384615	0.1923075
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.00384615	0.1923075
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00384615	0.1923075
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.00384615	0.1923075
CRANIOTELENCEPHALIC DYSPLASIA	0.00384615	0.1923075
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.00384615	0.1923075
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.00384615	0.1923075
10Q22.3Q23.3 MICRODELETION SYNDROME	0.00384615	0.1923075
REVESZ SYNDROME	0.00384615	0.1923075
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.00384615	0.1923075
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.00384615	0.1923075
LISSENCEPHALY 2; LIS2	0.00384615	0.1923075
PHACE SYNDROME	0.00384615	0.1923075
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00384615	0.1923075
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00384615	0.1923075
MONOSOMY 18Q	0.00384615	0.1923075
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.00384615	0.1923075
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.00384615	0.1923075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.00384615	0.1923075
4Q21 MICRODELETION SYNDROME	0.00384615	0.1923075
MARSHALL-SMITH SYNDROME	0.00384615	0.1923075
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.00384615	0.1923075
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00384615	0.1923075
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1; HGPPS1	0.00384615	0.1923075
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00384615	0.1923075
COFFIN-SIRIS SYNDROME 5	0.00384615	0.1923075
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.00384615	0.1923075
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00384615	0.1923075
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.00384615	0.1923075
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.00384615	0.1923075
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00384615	0.1923075
LIGNEOUS CONJUNCTIVITIS	0.00384615	0.1923075
CEREBELLOFACIODENTAL SYNDROME	0.00384615	0.1923075
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00384615	0.1923075
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00384615	0.1923075
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00384615	0.1923075
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.00384615	0.1923075
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.00384615	0.1923075
SECKEL SYNDROME 2; SCKL2	0.00384615	0.1923075
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.00384615	0.1923075
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00384615	0.1923075
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00384615	0.1923075
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.00384615	0.1923075
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00384615	0.1923075
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.00384615	0.1923075
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.00384615	0.1923075
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.00384615	0.1923075
LISSENCEPHALY 4	0.00384615	0.1923075
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.00384615	0.1923075
CROUZON DISEASE	0.00384615	0.1923075
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.00384615	0.1923075
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00384615	0.1923075
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.00384615	0.1923075
GILLESPIE SYNDROME; GLSP	0.00384615	0.1923075
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.00384615	0.1923075
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.00384615	0.1923075
CRANIOTELENCEPHALIC DYSPLASIA	0.00384615	0.1923075
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00384615	0.1923075
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00359712	0.17985600000000002
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00359712	0.17985600000000002
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.00359712	0.17985600000000002
CILIARY DYSKINESIA, PRIMARY, 32; CILD32	0.00359712	0.17985600000000002
PAPILLON-LEFÈVRE SYNDROME	0.00359712	0.17985600000000002
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.00359712	0.17985600000000002
PARTIAL ATRIOVENTRICULAR CANAL	0.00359712	0.17985600000000002
PROLIDASE DEFICIENCY	0.00359712	0.17985600000000002
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.00359712	0.17985600000000002
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00359712	0.17985600000000002
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00359712	0.17985600000000002
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00359712	0.17985600000000002
CHOANAL ATRESIA	0.00359712	0.17985600000000002
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00359712	0.17985600000000002
GAUCHER DISEASE TYPE 3	0.00359712	0.17985600000000002
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00359712	0.17985600000000002
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00359712	0.17985600000000002
PULMONARY ALVEOLAR PROTEINOSIS WITH HYPOGAMMAGLOBULINEMIA; PAPHG	0.00359712	0.17985600000000002
SPINAL MUSCULAR ATROPHY, TYPE II	0.00359712	0.17985600000000002
ISOLATED AGAMMAGLOBULINEMIA	0.00359712	0.17985600000000002
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.00359712	0.17985600000000002
HARLEQUIN ICHTHYOSIS	0.00359712	0.17985600000000002
ALOPECIA ANTIBODY DEFICIENCY	0.00359712	0.17985600000000002
LYMPHANGIOLEIOMYOMATOSIS	0.00359712	0.17985600000000002
TOXIC EPIDERMAL NECROLYSIS	0.00359712	0.17985600000000002
CILIARY DYSKINESIA, PRIMARY, 39; CILD39	0.00359712	0.17985600000000002
GAMMA-HEAVY CHAIN DISEASE	0.00359712	0.17985600000000002
ATAXIA-TELANGIECTASIA	0.00359712	0.17985600000000002
LIPOID PROTEINOSIS	0.00359712	0.17985600000000002
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00359712	0.17985600000000002
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00359712	0.17985600000000002
MALT LYMPHOMA	0.00359712	0.17985600000000002
COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	0.00359712	0.17985600000000002
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.00359712	0.17985600000000002
XQ28 (MECP2) DUPLICATION	0.00359712	0.17985600000000002
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.00359712	0.17985600000000002
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00359712	0.17985600000000002
KRABBE DISEASE	0.00359712	0.17985600000000002
LICHTENSTEIN SYNDROME	0.00359712	0.17985600000000002
IMMUNODEFICIENCY 43	0.00359712	0.17985600000000002
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.00359712	0.17985600000000002
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.00359712	0.17985600000000002
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00359712	0.17985600000000002
IMMUNODEFICIENCY 32B; IMD32B	0.00359712	0.17985600000000002
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00359712	0.17985600000000002
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00359712	0.17985600000000002
MELNICK-NEEDLES SYNDROME	0.00359712	0.17985600000000002
NIEMANN-PICK DISEASE, TYPE B	0.00359712	0.17985600000000002
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00359712	0.17985600000000002
BLOOM SYNDROME	0.00359712	0.17985600000000002
IMMUNODEFICIENCY 57; IMD57	0.00359712	0.17985600000000002
YELLOW NAIL SYNDROME	0.00359712	0.17985600000000002
IMMUNODEFICIENCY 58; IMD58	0.00359712	0.17985600000000002
LARYNX ATRESIA	0.00359712	0.17985600000000002
ICF SYNDROME	0.00359712	0.17985600000000002
HEREDITARY OROTIC ACIDURIA	0.00359712	0.17985600000000002
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00359712	0.17985600000000002
BETA-MANNOSIDOSIS	0.00359712	0.17985600000000002
ALSTRÖM SYNDROME	0.00359712	0.17985600000000002
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00359712	0.17985600000000002
CILIARY DYSKINESIA, PRIMARY, 17; CILD17	0.00359712	0.17985600000000002
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00359712	0.17985600000000002
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00359712	0.17985600000000002
ALPHA-MANNOSIDOSIS	0.00359712	0.17985600000000002
AORTIC ARCH DEFECTS	0.00359712	0.17985600000000002
CYSTIC FIBROSIS	0.00359712	0.17985600000000002
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.00359712	0.17985600000000002
CYSTIC HAMARTOMA OF LUNG AND KIDNEY	0.00359712	0.17985600000000002
CD8 DEFICIENCY, FAMILIAL	0.00359712	0.17985600000000002
VAN DEN BOSCH SYNDROME	0.00359712	0.17985600000000002
OPSISMODYSPLASIA	0.00359712	0.17985600000000002
DYSKERATOSIS CONGENITA	0.00359712	0.17985600000000002
FAMILIAL DYSAUTONOMIA	0.00359712	0.17985600000000002
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.00359712	0.17985600000000002
SECKEL SYNDROME 9; SCKL9	0.00359712	0.17985600000000002
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.00359712	0.17985600000000002
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00359712	0.17985600000000002
FARBER DISEASE	0.00359712	0.17985600000000002
IMMUNODEFICIENCY 36; IMD36	0.00359712	0.17985600000000002
DERMATOMYOSITIS	0.00359712	0.17985600000000002
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00359712	0.17985600000000002
RETICULAR DYSGENESIS	0.00359712	0.17985600000000002
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.00359712	0.17985600000000002
HEREDITARY FOLATE MALABSORPTION	0.00359712	0.17985600000000002
PAROXYSMAL COLD HEMOGLOBINURIA	0.00359712	0.17985600000000002
PRIMARY ERYTHROMELALGIA	0.00359712	0.17985600000000002
GRANULOMATOSIS WITH POLYANGIITIS	0.00359712	0.17985600000000002
GOOD SYNDROME	0.00359712	0.17985600000000002
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.00359712	0.17985600000000002
CHÉDIAK-HIGASHI SYNDROME	0.00359712	0.17985600000000002
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00359712	0.17985600000000002
ZLOTOGORA-OGUR SYNDROME	0.00359712	0.17985600000000002
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.00359712	0.17985600000000002
ASPARTYLGLUCOSAMINURIA	0.00359712	0.17985600000000002
CILIARY DYSKINESIA, PRIMARY, 35; CILD35	0.00359712	0.17985600000000002
CILIARY DYSKINESIA, PRIMARY, 7; CILD7	0.00359712	0.17985600000000002
GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF	0.00359712	0.17985600000000002
PELIZAEUS-MERZBACHER DISEASE	0.00359712	0.17985600000000002
IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1	0.00359712	0.17985600000000002
CYCLIC NEUTROPENIA	0.00359712	0.17985600000000002
ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	0.00359712	0.17985600000000002
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.00359712	0.17985600000000002
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.00359712	0.17985600000000002
EARLY MYOCLONIC ENCEPHALOPATHY	0.00359712	0.17985600000000002
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00359712	0.17985600000000002
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00359712	0.17985600000000002
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00359712	0.17985600000000002
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00359712	0.17985600000000002
SCIMITAR SYNDROME	0.00359712	0.17985600000000002
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00359712	0.17985600000000002
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00359712	0.17985600000000002
ATAXIA-PANCYTOPENIA SYNDROME	0.00359712	0.17985600000000002
SEVERE COMBINED IMMUNODEFICIENCY	0.00359712	0.17985600000000002
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00359712	0.17985600000000002
PULMONARY ARTERIAL HYPERTENSION	0.00359712	0.17985600000000002
CHOREOACANTHOCYTOSIS	0.00359712	0.17985600000000002
IMMUNODEFICIENCY 53; IMD53	0.00359712	0.17985600000000002
ANTISYNTHETASE SYNDROME	0.00359712	0.17985600000000002
ODONTOCHONDRODYSPLASIA; ODCD	0.00359712	0.17985600000000002
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00359712	0.17985600000000002
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00359712	0.17985600000000002
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.00359712	0.17985600000000002
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.00359712	0.17985600000000002
STEVENS-JOHNSON SYNDROME	0.00359712	0.17985600000000002
CILIARY DYSKINESIA, PRIMARY, 29; CILD29	0.00359712	0.17985600000000002
THORACIC DYSOSTOSIS, ISOLATED	0.00359712	0.17985600000000002
TAY-SACHS DISEASE	0.00359712	0.17985600000000002
SPASTIC PARAPLEGIA TYPE 2	0.00359712	0.17985600000000002
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.00359712	0.17985600000000002
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.00359712	0.17985600000000002
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00359712	0.17985600000000002
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00359712	0.17985600000000002
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00359712	0.17985600000000002
IMMUNODEFICIENCY 22; IMD22	0.00359712	0.17985600000000002
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00359712	0.17985600000000002
LOCKED-IN SYNDROME	0.00359712	0.17985600000000002
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.00359712	0.17985600000000002
PRIMARY CILIARY DYSKINESIA	0.00359712	0.17985600000000002
LAMELLAR ICHTHYOSIS	0.00359712	0.17985600000000002
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00359712	0.17985600000000002
SANDHOFF DISEASE	0.00359712	0.17985600000000002
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.00359712	0.17985600000000002
HURLER-SCHEIE SYNDROME	0.00359712	0.17985600000000002
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.00359712	0.17985600000000002
RETINITIS PIGMENTOSA 6	0.00359712	0.17985600000000002
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.00359712	0.17985600000000002
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.0029103799999999997	0.14551899999999998
DIABETIC EMBRYOPATHY	0.0029103799999999997	0.14551899999999998
KABUKI SYNDROME	0.0029103799999999997	0.14551899999999998
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.0029103799999999997	0.14551899999999998
CORNELIA DE LANGE SYNDROME	0.0029103799999999997	0.14551899999999998
PETERS-PLUS SYNDROME; PTRPLS	0.0029103799999999997	0.14551899999999998
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.0029103799999999997	0.14551899999999998
KBG SYNDROME	0.0029103799999999997	0.14551899999999998
KALLMANN SYNDROME	0.0029103799999999997	0.14551899999999998
FEMORAL-FACIAL SYNDROME	0.0029103799999999997	0.14551899999999998
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.0029103799999999997	0.14551899999999998
3MC SYNDROME 2	0.0029103799999999997	0.14551899999999998
CRANE-HEISE SYNDROME	0.0029103799999999997	0.14551899999999998
FRYNS SYNDROME	0.0029103799999999997	0.14551899999999998
SCHNECKENBECKEN DYSPLASIA	0.0029103799999999997	0.14551899999999998
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.0029103799999999997	0.14551899999999998
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.0029103799999999997	0.14551899999999998
GENITOPALATOCARDIAC SYNDROME	0.0029103799999999997	0.14551899999999998
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.0029103799999999997	0.14551899999999998
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0029103799999999997	0.14551899999999998
FETAL HYDANTOIN SYNDROME	0.0029103799999999997	0.14551899999999998
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.0029103799999999997	0.14551899999999998
TRISOMY 13	0.0029103799999999997	0.14551899999999998
TRIPLOIDY	0.0029103799999999997	0.14551899999999998
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.0029103799999999997	0.14551899999999998
FOCAL DERMAL HYPOPLASIA; FDH	0.0029103799999999997	0.14551899999999998
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.0029103799999999997	0.14551899999999998
CHROMOSOME 15Q25 DELETION SYNDROME	0.0029103799999999997	0.14551899999999998
DISTAL MONOSOMY 7Q36	0.0029103799999999997	0.14551899999999998
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.0029103799999999997	0.14551899999999998
DISTAL MONOSOMY 3P	0.0029103799999999997	0.14551899999999998
DISTAL MONOSOMY 15Q	0.0029103799999999997	0.14551899999999998
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.0029103799999999997	0.14551899999999998
C SYNDROME	0.0029103799999999997	0.14551899999999998
PHOCOMELIA, SCHINZEL TYPE	0.0029103799999999997	0.14551899999999998
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.0029103799999999997	0.14551899999999998
MCKUSICK-KAUFMAN SYNDROME	0.0029103799999999997	0.14551899999999998
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.0029103799999999997	0.14551899999999998
DISTAL MONOSOMY 10P	0.0029103799999999997	0.14551899999999998
ANKYLOBLEPHARON FILIFORME ADNATUM-IMPERFORATE ANUS SYNDROME	0.0029103799999999997	0.14551899999999998
CORNELIA DE LANGE SYNDROME 3	0.0029103799999999997	0.14551899999999998
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.0029103799999999997	0.14551899999999998
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.0029103799999999997	0.14551899999999998
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.0029103799999999997	0.14551899999999998
CHARGE SYNDROME	0.0029103799999999997	0.14551899999999998
BECKWITH-WIEDEMANN SYNDROME	0.0029103799999999997	0.14551899999999998
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.0029103799999999997	0.14551899999999998
TREACHER-COLLINS SYNDROME	0.0029103799999999997	0.14551899999999998
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.0029103799999999997	0.14551899999999998
CULLER-JONES SYNDROME; CJS	0.0029103799999999997	0.14551899999999998
POPLITEAL PTERYGIUM SYNDROME	0.0029103799999999997	0.14551899999999998
MECKEL SYNDROME	0.0029103799999999997	0.14551899999999998
22Q11.2 DELETION SYNDROME	0.0029103799999999997	0.14551899999999998
FACIOCARDIORENAL SYNDROME	0.0029103799999999997	0.14551899999999998
HARTSFIELD SYNDROME; HRTFDS	0.0029103799999999997	0.14551899999999998
KOOLEN-DE VRIES SYNDROME	0.0029103799999999997	0.14551899999999998
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.0029103799999999997	0.14551899999999998
MONOSOMY 9P	0.0029103799999999997	0.14551899999999998
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.0029103799999999997	0.14551899999999998
BRESEK SYNDROME	0.0029103799999999997	0.14551899999999998
PETERS PLUS SYNDROME	0.0029103799999999997	0.14551899999999998
TYSHCHENKO SYNDROME	0.0029103799999999997	0.14551899999999998
CHARGE SYNDROME	0.0029103799999999997	0.14551899999999998
ABRUZZO-ERICKSON SYNDROME	0.0029103799999999997	0.14551899999999998
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.0029103799999999997	0.14551899999999998
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.0029103799999999997	0.14551899999999998
FANCONI ANEMIA	0.0029103799999999997	0.14551899999999998
SMITH-FINEMAN-MYERS SYNDROME	0.0029103799999999997	0.14551899999999998
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.0029103799999999997	0.14551899999999998
MEIER-GORLIN SYNDROME 7	0.0029103799999999997	0.14551899999999998
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.0029103799999999997	0.14551899999999998
SMITH-LEMLI-OPITZ SYNDROME	0.0029103799999999997	0.14551899999999998
SAETHRE-CHOTZEN SYNDROME	0.0029103799999999997	0.14551899999999998
ATELOSTEOGENESIS, TYPE I; AO1	0.0029103799999999997	0.14551899999999998
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.0029103799999999997	0.14551899999999998
LARSEN SYNDROME	0.0029103799999999997	0.14551899999999998
OCULOCEREBROCUTANEOUS SYNDROME	0.0029103799999999997	0.14551899999999998
VACTERL/VATER ASSOCIATION	0.0029103799999999997	0.14551899999999998
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0025849180000000003	0.12924590000000002
MICROTRIPLICATION 11Q24.1	0.0025849180000000003	0.12924590000000002
MEHMO SYNDROME; MEHMO	0.0025849180000000003	0.12924590000000002
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0025849180000000003	0.12924590000000002
LARSEN-LIKE SYNDROME	0.0025849180000000003	0.12924590000000002
MENTAL RETARDATION, X-LINKED 102	0.0025849180000000003	0.12924590000000002
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.0025849180000000003	0.12924590000000002
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.0025849180000000003	0.12924590000000002
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.0025849180000000003	0.12924590000000002
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.0025849180000000003	0.12924590000000002
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0025849180000000003	0.12924590000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.0025849180000000003	0.12924590000000002
RITSCHER-SCHINZEL SYNDROME 1	0.0025849180000000003	0.12924590000000002
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0025849180000000003	0.12924590000000002
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.0025849180000000003	0.12924590000000002
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.0025849180000000003	0.12924590000000002
COFFIN-SIRIS SYNDROME 6; CSS6	0.0025849180000000003	0.12924590000000002
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.0025849180000000003	0.12924590000000002
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0025849180000000003	0.12924590000000002
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0025849180000000003	0.12924590000000002
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.0025849180000000003	0.12924590000000002
CAMPOMELIC DYSPLASIA	0.0025849180000000003	0.12924590000000002
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0025849180000000003	0.12924590000000002
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.0025849180000000003	0.12924590000000002
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0025849180000000003	0.12924590000000002
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.002248538	0.1124269
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.002248538	0.1124269
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.002248538	0.1124269
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.002248538	0.1124269
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.002248538	0.1124269
MEND SYNDROME; MEND	0.002248538	0.1124269
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.002248538	0.1124269
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.002248538	0.1124269
NOONAN SYNDROME 6; NS6	0.002248538	0.1124269
SIFRIM-HITZ-WEISS SYNDROME	0.002248538	0.1124269
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002248538	0.1124269
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.002248538	0.1124269
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.002248538	0.1124269
STT3A-CDG	0.002248538	0.1124269
STT3B-CDG	0.002248538	0.1124269
MICROPHTHALMIA, SYNDROMIC 3	0.002248538	0.1124269
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.002248538	0.1124269
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.002248538	0.1124269
JOHANSON-BLIZZARD SYNDROME; JBS	0.002248538	0.1124269
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.002248538	0.1124269
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.002248538	0.1124269
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.002248538	0.1124269
C SYNDROME	0.002248538	0.1124269
MENTAL RETARDATION, X-LINKED 93	0.002248538	0.1124269
VAN MALDERGEM SYNDROME 2; VMLDS2	0.002248538	0.1124269
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.002248538	0.1124269
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.002248538	0.1124269
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.002248538	0.1124269
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.002248538	0.1124269
TONNE-KALSCHEUER SYNDROME; TOKAS	0.002248538	0.1124269
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.002248538	0.1124269
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.002248538	0.1124269
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.002248538	0.1124269
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.002248538	0.1124269
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.002248538	0.1124269
PITT-HOPKINS SYNDROME	0.002248538	0.1124269
BARAITSER-WINTER SYNDROME 1; BRWS1	0.002248538	0.1124269
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.002248538	0.1124269
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.002248538	0.1124269
DUPLICATION/INVERSION 15Q11	0.002248538	0.1124269
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.002248538	0.1124269
OGDEN SYNDROME	0.002248538	0.1124269
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.002248538	0.1124269
CHROMOSOME 16P13.2 DELETION SYNDROME	0.002248538	0.1124269
OHDO SYNDROME	0.002248538	0.1124269
CODAS SYNDROME	0.002248538	0.1124269
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.002248538	0.1124269
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.002248538	0.1124269
CHROMOSOME 10Q26 DELETION SYNDROME	0.002248538	0.1124269
LATERAL MENINGOCELE SYNDROME	0.002248538	0.1124269
DIAMOND-BLACKFAN ANEMIA 10	0.00162338	0.081169
OROFACIODIGITAL SYNDROME X	0.00162338	0.081169
RENPENNING SYNDROME	0.00162338	0.081169
PALATOPHARYNGEAL INCOMPETENCE	0.00162338	0.081169
STICKLER SYNDROME TYPE 2	0.00162338	0.081169
PFEIFFER SYNDROME TYPE 3	0.00162338	0.081169
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.00162338	0.081169
OTOPALATODIGITAL SYNDROME TYPE 1	0.00162338	0.081169
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00162338	0.081169
STICKLER SYNDROME TYPE 1	0.00162338	0.081169
17Q12 MICRODUPLICATION SYNDROME	0.00162338	0.081169
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00162338	0.081169
RENAL AGENESIS, BILATERAL	0.00162338	0.081169
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.00162338	0.081169
THOMAS SYNDROME	0.00162338	0.081169
OROFACIODIGITAL SYNDROME TYPE 1	0.00162338	0.081169
TETRAPLOIDY	0.00162338	0.081169
OPITZ G/BBB SYNDROME	0.00162338	0.081169
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.00162338	0.081169
HEMIFACIAL MICROSOMIA	0.00162338	0.081169
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00162338	0.081169
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00162338	0.081169
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00162338	0.081169
CONGENITAL LARYNGOMALACIA	0.00162338	0.081169
FRONTOFACIONASAL DYSPLASIA	0.00162338	0.081169
MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	0.00162338	0.081169
NEU-LAXOVA SYNDROME 2; NLS2	0.00162338	0.081169
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.00162338	0.081169
PFEIFFER SYNDROME TYPE 2	0.00162338	0.081169
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.00162338	0.081169
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00162338	0.081169
OROFACIODIGITAL SYNDROME XI; OFD11	0.00162338	0.081169
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00162338	0.081169
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00162338	0.081169
22Q11.2 MICRODUPLICATION SYNDROME	0.00162338	0.081169
NAIL-PATELLA SYNDROME	0.00162338	0.081169
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00162338	0.081169
ACROCRANIOFACIAL DYSOSTOSIS	0.00162338	0.081169
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.00162338	0.081169
MECKEL SYNDROME, TYPE 4; MKS4	0.00162338	0.081169
%119530 OROFACIAL CLEFT 1; OFC1;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 1;;OROFACIAL CLEFT, NONSYNDROMIC; OFC;;CLEFT LIP/PALATE, NONSYNDROMIC	0.00162338	0.081169
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.00162338	0.081169
ISOLATED DANDY-WALKER MALFORMATION	0.00162338	0.081169
HOLZGREVE SYNDROME	0.00162338	0.081169
CLEIDOCRANIAL DYSPLASIA; CCD	0.00162338	0.081169
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00162338	0.081169
RHIZOMELIC SYNDROME, URBACH TYPE	0.00162338	0.081169
JOHNSON NEUROECTODERMAL SYNDROME	0.00162338	0.081169
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.00162338	0.081169
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00162338	0.081169
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.00162338	0.081169
ACRORENAL SYNDROME	0.00162338	0.081169
HEMIMELIA	0.00162338	0.081169
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.00162338	0.081169
CHARGE-LIKE SYNDROME, X-LINKED	0.00162338	0.081169
BASAL CELL NEVUS SYNDROME	0.00162338	0.081169
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00162338	0.081169
ISOTRETINOIN-LIKE SYNDROME	0.00162338	0.081169
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.00162338	0.081169
2Q33.1 DELETION SYNDROME	0.00162338	0.081169
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00162338	0.081169
CDAGS SYNDROME	0.00162338	0.081169
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00162338	0.081169
ISOTRETINOIN SYNDROME	0.00162338	0.081169
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00162338	0.081169
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00162338	0.081169
DIAMOND-BLACKFAN ANEMIA 1	0.00162338	0.081169
ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE	0.00162338	0.081169
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.00162338	0.081169
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.00162338	0.081169
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00162338	0.081169
STICKLER SYNDROME, TYPE I	0.00162338	0.081169
HARTSFIELD SYNDROME	0.00162338	0.081169
MECKEL SYNDROME, TYPE 5	0.00162338	0.081169
LYMPHEDEMA, HEREDITARY, II	0.00162338	0.081169
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00162338	0.081169
FACIOCARDIORENAL SYNDROME	0.00162338	0.081169
ISOLATED KLIPPEL-FEIL SYNDROME	0.00162338	0.081169
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.00162338	0.081169
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00162338	0.081169
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.00162338	0.081169
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.00162338	0.081169
LETHAL KNIEST-LIKE DYSPLASIA	0.00162338	0.081169
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00162338	0.081169
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00162338	0.081169
FETAL ALCOHOL SYNDROME	0.00162338	0.081169
OKAMOTO SYNDROME	0.00162338	0.081169
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00162338	0.081169
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00162338	0.081169
EEC SYNDROME	0.00162338	0.081169
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00162338	0.081169
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00162338	0.081169
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00162338	0.081169
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.00162338	0.081169
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00162338	0.081169
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00162338	0.081169
DISTAL MONOSOMY 19P13.3	0.00162338	0.081169
OCULO-PALATO-CEREBRAL SYNDROME	0.00162338	0.081169
THORACOABDOMINAL SYNDROME	0.00162338	0.081169
CHROMOSOME 15Q14 DELETION SYNDROME	0.00162338	0.081169
MECKEL SYNDROME, TYPE 6; MKS6	0.00162338	0.081169
SPRENGEL DEFORMITY	0.00162338	0.081169
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.00162338	0.081169
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00162338	0.081169
CLEFT PALATE	0.00162338	0.081169
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.00162338	0.081169
CLEFT PALATE-STAPES FIXATION-OLIGODONTIA SYNDROME	0.00162338	0.081169
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00162338	0.081169
TRISOMY 12P	0.00162338	0.081169
HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	0.00162338	0.081169
TRIOPIA	0.00162338	0.081169
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00162338	0.081169
MAXILLONASAL DYSPLASIA	0.00162338	0.081169
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00162338	0.081169
BARTSOCAS-PAPAS SYNDROME	0.00162338	0.081169
BAMFORTH-LAZARUS SYNDROME	0.00162338	0.081169
BALLER-GEROLD SYNDROME	0.00162338	0.081169
ATELOSTEOGENESIS, TYPE II	0.00162338	0.081169
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00162338	0.081169
OROFACIODIGITAL SYNDROME TYPE 14	0.00162338	0.081169
ATELOSTEOGENESIS TYPE I	0.00162338	0.081169
SCHISIS ASSOCIATION	0.00162338	0.081169
SPONDYLOEPIPHYSEAL DYSPLASIA AND SPONDYLOEPIMETAPHYSEAL DYSPLASIA	0.00162338	0.081169
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00162338	0.081169
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00162338	0.081169
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00162338	0.081169
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00162338	0.081169
DIAPHANOSPONDYLODYSOSTOSIS	0.00162338	0.081169
PARC SYNDROME	0.00162338	0.081169
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00162338	0.081169
3MC SYNDROME 1	0.00162338	0.081169
HISTIOCYTOID CARDIOMYOPATHY	0.00162338	0.081169
CAREY-FINEMAN-ZITER SYNDROME	0.00162338	0.081169
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.00162338	0.081169
PENTALOGY OF CANTRELL	0.00162338	0.081169
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00162338	0.081169
PARIETAL FORAMINA	0.00162338	0.081169
OCULOPALATOCEREBRAL SYNDROME	0.00162338	0.081169
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.00162338	0.081169
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00162338	0.081169
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.00162338	0.081169
ISOLATED PIERRE ROBIN SYNDROME	0.00162338	0.081169
CAMPOMELIA, CUMMING TYPE	0.00162338	0.081169
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00162338	0.081169
DYSRAPHISM-CLEFT LIP/PALATE-LIMB REDUCTION DEFECTS SYNDROME	0.00162338	0.081169
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00162338	0.081169
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.00162338	0.081169
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00162338	0.081169
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00162338	0.081169
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00162338	0.081169
BRANCHIOGENIC DEAFNESS SYNDROME	0.00162338	0.081169
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.00162338	0.081169
3MC SYNDROME 3	0.00162338	0.081169
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.00162338	0.081169
KNIEST-LIKE DYSPLASIA, LETHAL	0.00162338	0.081169
KERATODERMA HEREDITARIUM MUTILANS	0.00162338	0.081169
KNIEST DYSPLASIA	0.00162338	0.081169
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00162338	0.081169
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.00162338	0.081169
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00162338	0.081169
2Q32Q33 MICRODELETION SYNDROME	0.00162338	0.081169
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.00162338	0.081169
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00162338	0.081169
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.00162338	0.081169
TREACHER COLLINS SYNDROME 3; TCS3	0.00162338	0.081169
ROSSELLI-GULIENETTI SYNDROME	0.00162338	0.081169
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.00162338	0.081169
19P13.3 MICRODUPLICATION SYNDROME	0.00162338	0.081169
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.00162338	0.081169
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.00162338	0.081169
MUCOLIPIDOSIS TYPE III	0.00162338	0.081169
ANKYLOBLEPHARON FILIFORME ADNATUM-CLEFT PALATE SYNDROME	0.00162338	0.081169
BOR SYNDROME	0.00162338	0.081169
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00162338	0.081169
HOLZGREVE SYNDROME	0.00162338	0.081169
NIJMEGEN BREAKAGE SYNDROME	0.00162338	0.081169
MARSHALL SYNDROME	0.00162338	0.081169
MARFAN SYNDROME	0.00162338	0.081169
GENITOPALATOCARDIAC SYNDROME	0.00162338	0.081169
BRANCHIOOTIC SYNDROME	0.00162338	0.081169
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00162338	0.081169
OCULOAURICULOFRONTONASAL SYNDROME	0.00162338	0.081169
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00162338	0.081169
OROFACIODIGITAL SYNDROME IV; OFD4	0.00162338	0.081169
SMITH-MAGENIS SYNDROME	0.00162338	0.081169
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.00162338	0.081169
RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE	0.00162338	0.081169
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00162338	0.081169
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00162338	0.081169
ACROCRANIOFACIAL DYSOSTOSIS	0.00162338	0.081169
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00162338	0.081169
TROCHLEA OF THE HUMERUS, APLASIA OF	0.00162338	0.081169
RETINOBLASTOMA; RB1	0.00162338	0.081169
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00162338	0.081169
STICKLER SYNDROME, TYPE III	0.00162338	0.081169
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.00162338	0.081169
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.00162338	0.081169
RAPADILINO SYNDROME	0.00162338	0.081169
LOWRY-MACLEAN SYNDROME	0.00162338	0.081169
MONOSOMY 18P	0.00162338	0.081169
WEAVER-WILLIAMS SYNDROME	0.00162338	0.081169
15Q14 MICRODELETION SYNDROME	0.00162338	0.081169
NEURALGIC AMYOTROPHY	0.00162338	0.081169
NAGER SYNDROME	0.00162338	0.081169
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.00162338	0.081169
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.00162338	0.081169
SCHNECKENBECKEN DYSPLASIA	0.00162338	0.081169
LOWRY-MACLEAN SYNDROME	0.00162338	0.081169
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.00162338	0.081169
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.00162338	0.081169
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00162338	0.081169
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00162338	0.081169
TREACHER COLLINS SYNDROME 2; TCS2	0.00162338	0.081169
SAY SYNDROME	0.00162338	0.081169
DISTAL MONOSOMY 9P	0.00162338	0.081169
AGNATHIA-OTOCEPHALY COMPLEX	0.00162338	0.081169
SHORT RIB-POLYDACTYLY SYNDROME	0.00162338	0.081169
OTOMANDIBULAR SYNDROME	0.00162338	0.081169
DYSTONIA, JUVENILE-ONSET	0.00162338	0.081169
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00162338	0.081169
KYPHOMELIC DYSPLASIA	0.00162338	0.081169
MICROFORM HOLOPROSENCEPHALY	0.00162338	0.081169
CEREBROCOSTOMANDIBULAR SYNDROME	0.00162338	0.081169
OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6	0.00162338	0.081169
RETINOBLASTOMA	0.00162338	0.081169
PIERRE ROBIN SYNDROME	0.00162338	0.081169
CAMPOMELIC DYSPLASIA	0.00162338	0.081169
CHAND SYNDROME	0.00162338	0.081169
GOLDENHAR SYNDROME	0.00162338	0.081169
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00162338	0.081169
PIERRE ROBIN SYNDROME AND OLIGODACTYLY	0.00162338	0.081169
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00162338	0.081169
BARTSOCAS-PAPAS SYNDROME; BPS	0.00162338	0.081169
WAARDENBURG SYNDROME TYPE 1	0.00162338	0.081169
DIPROSOPUS	0.00162338	0.081169
VAN DER WOUDE SYNDROME	0.00162338	0.081169
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00162338	0.081169
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00162338	0.081169
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.00162338	0.081169
CHIME SYNDROME	0.00162338	0.081169
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00162338	0.081169
MECKEL SYNDROME, TYPE 10; MKS10	0.00162338	0.081169
XYLT1-CDG	0.00162338	0.081169
HOLOPROSENCEPHALY 11	0.00162338	0.081169
POLAND SYNDROME	0.001287	0.06434999999999999
NEUROFACIODIGITORENAL SYNDROME	0.001287	0.06434999999999999
PERSISTENT MÜLLERIAN DUCT SYNDROME	0.001287	0.06434999999999999
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001287	0.06434999999999999
601095 HARROD SYNDROME	0.001287	0.06434999999999999
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.001287	0.06434999999999999
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.001287	0.06434999999999999
VASCULAR EHLERS-DANLOS SYNDROME	0.001287	0.06434999999999999
WRINKLY SKIN SYNDROME	0.001287	0.06434999999999999
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.001287	0.06434999999999999
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.001287	0.06434999999999999
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.001287	0.06434999999999999
ELLIS VAN CREVELD SYNDROME	0.001287	0.06434999999999999
OCHOA SYNDROME	0.001287	0.06434999999999999
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.001287	0.06434999999999999
STEINERT MYOTONIC DYSTROPHY	0.001287	0.06434999999999999
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001287	0.06434999999999999
LATERAL MENINGOCELE SYNDROME	0.001287	0.06434999999999999
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.001287	0.06434999999999999
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.001287	0.06434999999999999
PITT-HOPKINS SYNDROME	0.001287	0.06434999999999999
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.001287	0.06434999999999999
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001287	0.06434999999999999
SCARF SYNDROME	0.001287	0.06434999999999999
PERLMAN SYNDROME	0.001287	0.06434999999999999
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.001287	0.06434999999999999
POLYDACTYLY-MYOPIA SYNDROME	0.001287	0.06434999999999999
REIFENSTEIN SYNDROME	0.001287	0.06434999999999999
NOONAN SYNDROME 10; NS10	0.001287	0.06434999999999999
N SYNDROME	0.001287	0.06434999999999999
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.001287	0.06434999999999999
ELSAHY-WATERS SYNDROME; ESWS	0.001287	0.06434999999999999
RUBINSTEIN-TAYBI SYNDROME	0.001287	0.06434999999999999
BLOOM SYNDROME	0.001287	0.06434999999999999
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.001287	0.06434999999999999
47,XYY SYNDROME	0.001287	0.06434999999999999
SILVER-RUSSELL SYNDROME	0.001287	0.06434999999999999
LUMBAR SYNDROME	0.001287	0.06434999999999999
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001287	0.06434999999999999
IMAGE SYNDROME	0.001287	0.06434999999999999
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.001287	0.06434999999999999
MEHMO SYNDROME	0.001287	0.06434999999999999
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	0.001287	0.06434999999999999
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.001287	0.06434999999999999
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.001287	0.06434999999999999
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.001287	0.06434999999999999
LEYDIG CELL HYPOPLASIA	0.001287	0.06434999999999999
ANDROGEN INSENSITIVITY SYNDROME	0.001287	0.06434999999999999
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 5-ALPHA-REDUCTASE 2 DEFICIENCY	0.001287	0.06434999999999999
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 17-BETA-HYDROXYSTEROID DEHYDROGENASE 3 DEFICIENCY	0.001287	0.06434999999999999
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001287	0.06434999999999999
COCKAYNE SYNDROME A; CSA	0.001287	0.06434999999999999
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.001287	0.06434999999999999
THROMBOCYTOPENIA WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA	0.001287	0.06434999999999999
CRANIOSYNOSTOSIS WITH FIBULAR APLASIA	0.001287	0.06434999999999999
CARPENTER SYNDROME	0.001287	0.06434999999999999
NORRIE DISEASE	0.001287	0.06434999999999999
NOONAN SYNDROME	0.001287	0.06434999999999999
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.001287	0.06434999999999999
NEUROFIBROMATOSIS TYPE 1	0.001287	0.06434999999999999
224250 DYSMYELINATION WITH JAUNDICE	0.001287	0.06434999999999999
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.001287	0.06434999999999999
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.001287	0.06434999999999999
TOWNES-BROCKS SYNDROME	0.001287	0.06434999999999999
RUVALCABA SYNDROME	0.001287	0.06434999999999999
ACRODYSOSTOSIS	0.001287	0.06434999999999999
8P23.1 DELETION SYNDROME	0.001287	0.06434999999999999
LIG4 SYNDROME	0.001287	0.06434999999999999
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.001287	0.06434999999999999
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.001287	0.06434999999999999
TOWNES-BROCKS SYNDROME 1; TBS1	0.001287	0.06434999999999999
CRI-DU-CHAT SYNDROME	0.001287	0.06434999999999999
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.001287	0.06434999999999999
BECKWITH-WIEDEMANN SYNDROME	0.001287	0.06434999999999999
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.001287	0.06434999999999999
FLOATING-HARBOR SYNDROME	0.001287	0.06434999999999999
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.001287	0.06434999999999999
HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7	0.001287	0.06434999999999999
PITUITARY STALK INTERRUPTION SYNDROME	0.001287	0.06434999999999999
CHROMOSOME 18P DELETION SYNDROME	0.001287	0.06434999999999999
PALLISTER-HALL SYNDROME	0.001287	0.06434999999999999
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001287	0.06434999999999999
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.001287	0.06434999999999999
JUBERG-MARSIDI SYNDROME	0.001287	0.06434999999999999
KBG SYNDROME	0.001287	0.06434999999999999
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.001287	0.06434999999999999
AUTOSOMAL DOMINANT OMODYSPLASIA	0.001287	0.06434999999999999
XERODERMA PIGMENTOSUM	0.001287	0.06434999999999999
AROMATASE DEFICIENCY	0.001287	0.06434999999999999
PARTIAL ANDROGEN INSENSITIVITY SYNDROME	0.001287	0.06434999999999999
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.001287	0.06434999999999999
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.001287	0.06434999999999999
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.001287	0.06434999999999999
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.001287	0.06434999999999999
OMODYSPLASIA	0.001287	0.06434999999999999
WAGR SYNDROME	0.001287	0.06434999999999999
ELLIS-VAN CREVELD SYNDROME	0.001287	0.06434999999999999
FANCONI ANEMIA	0.001287	0.06434999999999999
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.001287	0.06434999999999999
7P22.1 MICRODUPLICATION SYNDROME	0.001287	0.06434999999999999
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.001287	0.06434999999999999
MMEP SYNDROME	0.001287	0.06434999999999999
VACTERL WITH HYDROCEPHALUS	0.001287	0.06434999999999999
ULBRIGHT-HODES SYNDROME	0.001287	0.06434999999999999
OLIVER-MCFARLANE SYNDROME	0.001287	0.06434999999999999
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.001287	0.06434999999999999
TETRALOGY OF FALLOT	0.001287	0.06434999999999999
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.001287	0.06434999999999999
ADRENAL HYPOPLASIA, CONGENITAL	0.001287	0.06434999999999999
FILIPPI SYNDROME	0.001287	0.06434999999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.001287	0.06434999999999999
OGDEN SYNDROME; OGDNS	0.001287	0.06434999999999999
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.001287	0.06434999999999999
MENTAL RETARDATION, X-LINKED 106; MRX106	0.001287	0.06434999999999999
SCARF SYNDROME	0.001287	0.06434999999999999
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.001287	0.06434999999999999
RUVALCABA SYNDROME	0.001287	0.06434999999999999
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001287	0.06434999999999999
MEACHAM SYNDROME	0.001287	0.06434999999999999
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.001287	0.06434999999999999
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.001287	0.06434999999999999
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.001287	0.06434999999999999
COSTELLO SYNDROME	0.001287	0.06434999999999999
GLYCEROL KINASE DEFICIENCY; GKD	0.001287	0.06434999999999999
ICHTHYOSIS, X-LINKED	0.001287	0.06434999999999999
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.001287	0.06434999999999999
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.001287	0.06434999999999999
CAUDAL REGRESSION SEQUENCE	0.001287	0.06434999999999999
QAZI-MARKOUIZOS SYNDROME	0.001287	0.06434999999999999
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.001287	0.06434999999999999
WILSON-TURNER SYNDROME	0.001287	0.06434999999999999
TESTICULAR GERM CELL TUMOR; TGCT	0.001287	0.06434999999999999
9Q21.13 MICRODELETION SYNDROME	0.001287	0.06434999999999999
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001287	0.06434999999999999
ALAGILLE SYNDROME	0.001287	0.06434999999999999
UROFACIAL SYNDROME	0.001287	0.06434999999999999
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.001287	0.06434999999999999
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.001287	0.06434999999999999
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.001287	0.06434999999999999
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001287	0.06434999999999999
9Q33.3Q34.11 MICRODELETION SYNDROME	0.001287	0.06434999999999999
PENILE AGENESIS	0.001287	0.06434999999999999
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.001287	0.06434999999999999
MCDONOUGH SYNDROME	0.001287	0.06434999999999999
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001287	0.06434999999999999
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.001287	0.06434999999999999
RECESSIVE X-LINKED ICHTHYOSIS	0.001287	0.06434999999999999
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.001287	0.06434999999999999
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.001287	0.06434999999999999
FILIPPI SYNDROME; FLPIS	0.001287	0.06434999999999999
CONGENITAL ADRENAL HYPERPLASIA	0.001287	0.06434999999999999
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001287	0.06434999999999999
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.001287	0.06434999999999999
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001287	0.06434999999999999
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.001287	0.06434999999999999
14Q24.1Q24.3 MICRODELETION SYNDROME	0.001287	0.06434999999999999
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.001287	0.06434999999999999
OMODYSPLASIA 1; OMOD1	0.001287	0.06434999999999999
GORLIN SYNDROME	0.001287	0.06434999999999999
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.001287	0.06434999999999999
20Q11.2 MICRODUPLICATION SYNDROME	0.001287	0.06434999999999999
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.001287	0.06434999999999999
ACROCALLOSAL SYNDROME	0.001287	0.06434999999999999
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.001287	0.06434999999999999
ADNP SYNDROME	0.001287	0.06434999999999999
SOTOS SYNDROME	0.001287	0.06434999999999999
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.001287	0.06434999999999999
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001287	0.06434999999999999
HARROD SYNDROME	0.001287	0.06434999999999999
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.001287	0.06434999999999999
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.001287	0.06434999999999999
FRASER SYNDROME	0.001287	0.06434999999999999
ENDOCARDIAL FIBROELASTOSIS	0.001287	0.06434999999999999
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.001287	0.06434999999999999
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.001287	0.06434999999999999
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.001287	0.06434999999999999
TETRAGAMETIC CHIMERISM	0.001287	0.06434999999999999
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.001287	0.06434999999999999
MICROPHTHALMIA, SYNDROMIC 12	0.001287	0.06434999999999999
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.001287	0.06434999999999999
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.001287	0.06434999999999999
HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA; HH22	0.001287	0.06434999999999999
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.001287	0.06434999999999999
COHEN SYNDROME	0.001287	0.06434999999999999
TOLUENE EMBRYOPATHY	0.001287	0.06434999999999999
FETAL MINOXIDIL SYNDROME	0.001287	0.06434999999999999
DIETHYLSTILBESTROL SYNDROME	0.001287	0.06434999999999999
ALAZAMI-YUAN SYNDROME	0.001287	0.06434999999999999
ISOLATED HEMIHYPERPLASIA	0.001287	0.06434999999999999
NOONAN SYNDROME 5; NS5	0.001287	0.06434999999999999
PITT-HOPKINS-LIKE SYNDROME	0.001287	0.06434999999999999
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.001287	0.06434999999999999
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.001287	0.06434999999999999
NOONAN SYNDROME 3; NS3	0.001287	0.06434999999999999
DIPHALLIA	0.001287	0.06434999999999999
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.001287	0.06434999999999999
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.001287	0.06434999999999999
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.001287	0.06434999999999999
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.001287	0.06434999999999999
MIRAGE SYNDROME; MIRAGE	0.001287	0.06434999999999999
46,XX OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.001287	0.06434999999999999
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.001287	0.06434999999999999
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.001287	0.06434999999999999
NOONAN SYNDROME 4; NS4	0.001287	0.06434999999999999
HYDROLETHALUS	0.001287	0.06434999999999999
AUTOSOMAL RECESSIVE AMELIA	0.001287	0.06434999999999999
RIN2 SYNDROME	0.001287	0.06434999999999999
ANIRIDIA-ABSENT PATELLA SYNDROME	0.001287	0.06434999999999999
HAMAMY SYNDROME; HMMS	0.001287	0.06434999999999999
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.001287	0.06434999999999999
CHROMOSOME 1P35 DELETION SYNDROME	0.001287	0.06434999999999999
ACROMELIC FRONTONASAL DYSPLASIA	0.001287	0.06434999999999999
MEIER-GORLIN SYNDROME 3; MGORS3	0.001287	0.06434999999999999
GABRIELE-DE VRIES SYNDROME; GADEVS	0.001287	0.06434999999999999
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001287	0.06434999999999999
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.001287	0.06434999999999999
PARTIAL CHROMOSOME Y DELETION	0.001287	0.06434999999999999
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001287	0.06434999999999999
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.001287	0.06434999999999999
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.001287	0.06434999999999999
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.001287	0.06434999999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.001287	0.06434999999999999
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001287	0.06434999999999999
RING CHROMOSOME 12 SYNDROME	0.001287	0.06434999999999999
MEIER-GORLIN SYNDROME 5; MGORS5	0.001287	0.06434999999999999
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.001287	0.06434999999999999
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.001287	0.06434999999999999
RETINITIS PIGMENTOSA 59; RP59	0.001287	0.06434999999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.001287	0.06434999999999999
HYPERTELORISM, TEEBI TYPE	0.001287	0.06434999999999999
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.001287	0.06434999999999999
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.001287	0.06434999999999999
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.001287	0.06434999999999999
BARDET-BIEDL SYNDROME 4; BBS4	0.001287	0.06434999999999999
CAUDAL DUPLICATION	0.001287	0.06434999999999999
WEBB-DATTANI SYNDROME; WEDAS	0.001287	0.06434999999999999
BEEMER-ERTBRUGGEN SYNDROME	0.001287	0.06434999999999999
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.001287	0.06434999999999999
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.001287	0.06434999999999999
BOOMERANG DYSPLASIA	0.001287	0.06434999999999999
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.001287	0.06434999999999999
TRISOMY XQ28	0.001287	0.06434999999999999
MACS SYNDROME	0.001287	0.06434999999999999
CHROMOSOME 17Q12 DELETION SYNDROME	0.001287	0.06434999999999999
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.001287	0.06434999999999999
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.001287	0.06434999999999999
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.001287	0.06434999999999999
HEART DEFECT-TONGUE HAMARTOMA-POLYSYNDACTYLY SYNDROME	0.001287	0.06434999999999999
NON-DISTAL TRISOMY 13Q	0.001287	0.06434999999999999
CARDIOFACIOCUTANEOUS SYNDROME	0.001287	0.06434999999999999
HEART-HAND SYNDROME TYPE 2	0.001287	0.06434999999999999
NON-DISTAL TRISOMY 10Q	0.001287	0.06434999999999999
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.001287	0.06434999999999999
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.001287	0.06434999999999999
BARDET-BIEDL SYNDROME	0.001287	0.06434999999999999
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.001287	0.06434999999999999
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.001287	0.06434999999999999
1Q21.1 MICRODELETION SYNDROME	0.001287	0.06434999999999999
HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8	0.001287	0.06434999999999999
17Q12 MICRODELETION SYNDROME	0.001287	0.06434999999999999
46,XY PARTIAL GONADAL DYSGENESIS	0.001287	0.06434999999999999
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.001287	0.06434999999999999
CHOPS SYNDROME; CHOPS	0.001287	0.06434999999999999
LAURIN-SANDROW SYNDROME	0.001287	0.06434999999999999
N SYNDROME	0.001287	0.06434999999999999
CARDIAC-UROGENITAL SYNDROME; CUGS	0.001287	0.06434999999999999
OROFACIAL CLEFT 15	0.001287	0.06434999999999999
8P23.1 MICRODELETION SYNDROME	0.001287	0.06434999999999999
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001287	0.06434999999999999
HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA	0.001287	0.06434999999999999
1Q41Q42 MICRODELETION SYNDROME	0.001287	0.06434999999999999
8P11.2 DELETION SYNDROME	0.001287	0.06434999999999999
HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16	0.001287	0.06434999999999999
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.001287	0.06434999999999999
MCDONOUGH SYNDROME	0.001287	0.06434999999999999
MATTHEW-WOOD SYNDROME	0.001287	0.06434999999999999
2Q23.1 MICRODELETION SYNDROME	0.001287	0.06434999999999999
NOONAN SYNDROME 8; NS8	0.001287	0.06434999999999999
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.001287	0.06434999999999999
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001287	0.06434999999999999
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.001287	0.06434999999999999
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.001287	0.06434999999999999
14Q22Q23 MICRODELETION SYNDROME	0.001287	0.06434999999999999
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.001287	0.06434999999999999
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.001287	0.06434999999999999
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.001287	0.06434999999999999
CREE MENTAL RETARDATION SYNDROME	0.001287	0.06434999999999999
NOONAN SYNDROME 9; NS9	0.001287	0.06434999999999999
TEMPLE SYNDROME	0.001287	0.06434999999999999
LIG4 SYNDROME	0.001287	0.06434999999999999
CRANIOLENTICULOSUTURAL DYSPLASIA	0.001287	0.06434999999999999
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.001287	0.06434999999999999
LAURENCE-MOON SYNDROME	0.001287	0.06434999999999999
OSTEOGLOSPHONIC DYSPLASIA	0.001287	0.06434999999999999
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001287	0.06434999999999999
XQ27.3Q28 DUPLICATION SYNDROME	0.001287	0.06434999999999999
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.0009615380000000001	0.048076900000000006
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.0009615380000000001	0.048076900000000006
VISCERAL STEATOSIS, CONGENITAL	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0009615380000000001	0.048076900000000006
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.0009615380000000001	0.048076900000000006
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0009615380000000001	0.048076900000000006
JUVENILE POLYPOSIS OF INFANCY	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.0009615380000000001	0.048076900000000006
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.0009615380000000001	0.048076900000000006
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.0009615380000000001	0.048076900000000006
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0009615380000000001	0.048076900000000006
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0009615380000000001	0.048076900000000006
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0009615380000000001	0.048076900000000006
GLUTARIC ACIDEMIA I; GA1	0.0009615380000000001	0.048076900000000006
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.0009615380000000001	0.048076900000000006
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0009615380000000001	0.048076900000000006
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0009615380000000001	0.048076900000000006
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	0.048076900000000006
JOUBERT SYNDROME 21	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.0009615380000000001	0.048076900000000006
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.0009615380000000001	0.048076900000000006
FOLATE MALABSORPTION, HEREDITARY	0.0009615380000000001	0.048076900000000006
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0009615380000000001	0.048076900000000006
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.0009615380000000001	0.048076900000000006
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0009615380000000001	0.048076900000000006
GALACTOSE EPIMERASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0009615380000000001	0.048076900000000006
CHIARI MALFORMATION TYPE II	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.0009615380000000001	0.048076900000000006
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.0009615380000000001	0.048076900000000006
GRISCELLI SYNDROME TYPE 1	0.0009615380000000001	0.048076900000000006
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	0.048076900000000006
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0009615380000000001	0.048076900000000006
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.0009615380000000001	0.048076900000000006
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.0009615380000000001	0.048076900000000006
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.0009615380000000001	0.048076900000000006
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.0009615380000000001	0.048076900000000006
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0009615380000000001	0.048076900000000006
COFFIN-SIRIS SYNDROME 7; CSS7	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0009615380000000001	0.048076900000000006
KLEEFSTRA SYNDROME 2; KLEFS2	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.0009615380000000001	0.048076900000000006
TEMTAMY SYNDROME; TEMTYS	0.0009615380000000001	0.048076900000000006
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0009615380000000001	0.048076900000000006
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0009615380000000001	0.048076900000000006
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.0009615380000000001	0.048076900000000006
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0009615380000000001	0.048076900000000006
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.0009615380000000001	0.048076900000000006
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0009615380000000001	0.048076900000000006
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.0009615380000000001	0.048076900000000006
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.0009615380000000001	0.048076900000000006
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0009615380000000001	0.048076900000000006
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0009615380000000001	0.048076900000000006
GIANT AXONAL NEUROPATHY	0.0009615380000000001	0.048076900000000006
INFANTILE LIVER FAILURE SYNDROME 1	0.0009615380000000001	0.048076900000000006
EHLERS-DANLOS SYNDROME, TYPE VI	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0009615380000000001	0.048076900000000006
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.0009615380000000001	0.048076900000000006
SENGERS SYNDROME	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.0009615380000000001	0.048076900000000006
SPINOCEREBELLAR ATAXIA 47; SCA47	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0009615380000000001	0.048076900000000006
ETHANOLAMINOSIS	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0009615380000000001	0.048076900000000006
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0009615380000000001	0.048076900000000006
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.0009615380000000001	0.048076900000000006
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0009615380000000001	0.048076900000000006
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.0009615380000000001	0.048076900000000006
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0009615380000000001	0.048076900000000006
VERVERI-BRADY SYNDROME; VERBRAS	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.0009615380000000001	0.048076900000000006
JABERI-ELAHI SYNDROME; JABELS	0.0009615380000000001	0.048076900000000006
GRISCELLI SYNDROME, TYPE 1	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.0009615380000000001	0.048076900000000006
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.0009615380000000001	0.048076900000000006
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
RAPID-ONSET DYSTONIA-PARKINSONISM	0.0009615380000000001	0.048076900000000006
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0009615380000000001	0.048076900000000006
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0009615380000000001	0.048076900000000006
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0009615380000000001	0.048076900000000006
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.0009615380000000001	0.048076900000000006
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0009615380000000001	0.048076900000000006
YOU-HOOVER-FONG SYNDROME; YHFS	0.0009615380000000001	0.048076900000000006
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0009615380000000001	0.048076900000000006
HYPERCALCEMIA, INFANTILE, 1	0.0009615380000000001	0.048076900000000006
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.0009615380000000001	0.048076900000000006
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0009615380000000001	0.048076900000000006
ZIMMERMANN-LABAND SYNDROME 1	0.0009615380000000001	0.048076900000000006
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0009615380000000001	0.048076900000000006
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.0009615380000000001	0.048076900000000006
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.0009615380000000001	0.048076900000000006
WHITE-SUTTON SYNDROME; WHSUS	0.0009615380000000001	0.048076900000000006
LUSCAN-LUMISH SYNDROME; LLS	0.0009615380000000001	0.048076900000000006
RING CHROMOSOME 13 SYNDROME	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.0009615380000000001	0.048076900000000006
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0009615380000000001	0.048076900000000006
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0009615380000000001	0.048076900000000006
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.0009615380000000001	0.048076900000000006
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0009615380000000001	0.048076900000000006
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.0009615380000000001	0.048076900000000006
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.0009615380000000001	0.048076900000000006
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.0009615380000000001	0.048076900000000006
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0009615380000000001	0.048076900000000006
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.0009615380000000001	0.048076900000000006
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.0009615380000000001	0.048076900000000006
JOUBERT SYNDROME 27	0.0009615380000000001	0.048076900000000006
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.0009615380000000001	0.048076900000000006
NEUTRAL LIPID STORAGE MYOPATHY	0.0009615380000000001	0.048076900000000006
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0009615380000000001	0.048076900000000006
ANGELMAN SYNDROME	0.0009615380000000001	0.048076900000000006
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0009615380000000001	0.048076900000000006
DESANTO-SHINAWI SYNDROME	0.0009615380000000001	0.048076900000000006
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0009615380000000001	0.048076900000000006
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.0009615380000000001	0.048076900000000006
ADENYLOSUCCINASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.0009615380000000001	0.048076900000000006
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0009615380000000001	0.048076900000000006
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.0009615380000000001	0.048076900000000006
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.0009615380000000001	0.048076900000000006
RING CHROMOSOME 14 SYNDROME	0.0009615380000000001	0.048076900000000006
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0009615380000000001	0.048076900000000006
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0009615380000000001	0.048076900000000006
CRANIOSYNOSTOSIS 6; CRS6	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.0009615380000000001	0.048076900000000006
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.0009615380000000001	0.048076900000000006
AL-RAQAD SYNDROME; ARS	0.0009615380000000001	0.048076900000000006
SPINOCEREBELLAR ATAXIA TYPE 1	0.0009615380000000001	0.048076900000000006
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0009615380000000001	0.048076900000000006
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0009615380000000001	0.048076900000000006
LAMB-SHAFFER SYNDROME	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0009615380000000001	0.048076900000000006
SPINOCEREBELLAR ATAXIA TYPE 10	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.0009615380000000001	0.048076900000000006
SPINOCEREBELLAR ATAXIA TYPE 14	0.0009615380000000001	0.048076900000000006
SPINOCEREBELLAR ATAXIA TYPE 13	0.0009615380000000001	0.048076900000000006
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.0009615380000000001	0.048076900000000006
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.0009615380000000001	0.048076900000000006
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.0009615380000000001	0.048076900000000006
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.0009615380000000001	0.048076900000000006
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.0009615380000000001	0.048076900000000006
JOUBERT SYNDROME 28	0.0009615380000000001	0.048076900000000006
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.0009615380000000001	0.048076900000000006
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.0009615380000000001	0.048076900000000006
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0009615380000000001	0.048076900000000006
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.0009615380000000001	0.048076900000000006
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0009615380000000001	0.048076900000000006
XIA-GIBBS SYNDROME	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.0009615380000000001	0.048076900000000006
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0009615380000000001	0.048076900000000006
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0009615380000000001	0.048076900000000006
SMITH-MAGENIS SYNDROME; SMS	0.0009615380000000001	0.048076900000000006
SHPRINTZEN OMPHALOCELE SYNDROME	0.0009615380000000001	0.048076900000000006
AICARDI-GOUTIERES SYNDROME 7	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0009615380000000001	0.048076900000000006
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0009615380000000001	0.048076900000000006
HELSMOORTEL-VAN DER AA SYNDROME	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.0009615380000000001	0.048076900000000006
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.0009615380000000001	0.048076900000000006
JOUBERT SYNDROME 30; JBTS30	0.0009615380000000001	0.048076900000000006
CHROMOSOME 5Q12 DELETION SYNDROME	0.0009615380000000001	0.048076900000000006
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.0009615380000000001	0.048076900000000006
JOUBERT SYNDROME 31; JBTS31	0.0009615380000000001	0.048076900000000006
SUSAC SYNDROME	0.0009615380000000001	0.048076900000000006
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0009615380000000001	0.048076900000000006
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.0009615380000000001	0.048076900000000006
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0009615380000000001	0.048076900000000006
ACID PHOSPHATASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.0009615380000000001	0.048076900000000006
AL KAISSI SYNDROME; ALKAS	0.0009615380000000001	0.048076900000000006
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.0009615380000000001	0.048076900000000006
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0009615380000000001	0.048076900000000006
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.0009615380000000001	0.048076900000000006
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.0009615380000000001	0.048076900000000006
SHASHI-PENA SYNDROME; SHAPNS	0.0009615380000000001	0.048076900000000006
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	0.048076900000000006
HAREL-YOON SYNDROME; HAYOS	0.0009615380000000001	0.048076900000000006
MYOTONIC DYSTROPHY 1	0.0009615380000000001	0.048076900000000006
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.0009615380000000001	0.048076900000000006
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.0009615380000000001	0.048076900000000006
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.0009615380000000001	0.048076900000000006
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.0009615380000000001	0.048076900000000006
DYSTONIA 11, MYOCLONIC	0.0009615380000000001	0.048076900000000006
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0009615380000000001	0.048076900000000006
CHROMOSOME 9P DELETION SYNDROME	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.0009615380000000001	0.048076900000000006
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0009615380000000001	0.048076900000000006
SUDDEN CARDIAC FAILURE, INFANTILE	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0009615380000000001	0.048076900000000006
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.0009615380000000001	0.048076900000000006
PEROXISOME BIOGENESIS DISORDER 10B	0.0009615380000000001	0.048076900000000006
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0009615380000000001	0.048076900000000006
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0009615380000000001	0.048076900000000006
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	0.048076900000000006
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.0009615380000000001	0.048076900000000006
SPINOCEREBELLAR ATAXIA 1	0.0009615380000000001	0.048076900000000006
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0009615380000000001	0.048076900000000006
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.0009615380000000001	0.048076900000000006
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.0009615380000000001	0.048076900000000006
IMMUNODEFICIENCY 49; IMD49	0.0009615380000000001	0.048076900000000006
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0009615380000000001	0.048076900000000006
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0009615380000000001	0.048076900000000006
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.0009615380000000001	0.048076900000000006
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0009615380000000001	0.048076900000000006
SCHOLTE SYNDROME; SHLTS	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.0009615380000000001	0.048076900000000006
JOUBERT SYNDROME 8	0.0009615380000000001	0.048076900000000006
SIALURIA	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, X-LINKED 99	0.0009615380000000001	0.048076900000000006
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0009615380000000001	0.048076900000000006
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0009615380000000001	0.048076900000000006
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, X-LINKED 90	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, X-LINKED 41	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, X-LINKED 19	0.0009615380000000001	0.048076900000000006
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.0009615380000000001	0.048076900000000006
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.0009615380000000001	0.048076900000000006
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	0.048076900000000006
NEMALINE MYOPATHY 7; NEM7	0.0009615380000000001	0.048076900000000006
COFFIN-LOWRY SYNDROME; CLS	0.0009615380000000001	0.048076900000000006
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0009615380000000001	0.048076900000000006
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.0009615380000000001	0.048076900000000006
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.0009615380000000001	0.048076900000000006
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.0009615380000000001	0.048076900000000006
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.0009615380000000001	0.048076900000000006
LEGIUS SYNDROME	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0009615380000000001	0.048076900000000006
JOUBERT SYNDROME 7	0.0009615380000000001	0.048076900000000006
SHUKLA-VERNON SYNDROME; SHUVER	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.0009615380000000001	0.048076900000000006
COMBINED SAPOSIN DEFICIENCY	0.0009615380000000001	0.048076900000000006
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0009615380000000001	0.048076900000000006
SPINOCEREBELLAR ATAXIA TYPE 29	0.0009615380000000001	0.048076900000000006
TEMPLE-BARAITSER SYNDROME; TMBTS	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0009615380000000001	0.048076900000000006
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0009615380000000001	0.048076900000000006
NOONAN SYNDROME 7; NS7	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.0009615380000000001	0.048076900000000006
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0009615380000000001	0.048076900000000006
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0009615380000000001	0.048076900000000006
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.0009615380000000001	0.048076900000000006
CHROMOSOME 4Q21 DELETION SYNDROME	0.0009615380000000001	0.048076900000000006
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0009615380000000001	0.048076900000000006
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0009615380000000001	0.048076900000000006
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0009615380000000001	0.048076900000000006
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.0009615380000000001	0.048076900000000006
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.0009615380000000001	0.048076900000000006
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0009615380000000001	0.048076900000000006
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.0009615380000000001	0.048076900000000006
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.0009615380000000001	0.048076900000000006
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0009615380000000001	0.048076900000000006
EPILEPSY, HOT WATER, 1	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0009615380000000001	0.048076900000000006
GLYCOGEN STORAGE DISEASE IXC	0.0009615380000000001	0.048076900000000006
PORPHYRIA, ACUTE HEPATIC	0.0009615380000000001	0.048076900000000006
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.0009615380000000001	0.048076900000000006
ALG13-CDG	0.0009615380000000001	0.048076900000000006
LESCH-NYHAN SYNDROME; LNS	0.0009615380000000001	0.048076900000000006
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0009615380000000001	0.048076900000000006
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.0009615380000000001	0.048076900000000006
LISSENCEPHALY, X-LINKED, 2	0.0009615380000000001	0.048076900000000006
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.0009615380000000001	0.048076900000000006
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
LIVER FAILURE, INFANTILE, TRANSIENT	0.0009615380000000001	0.048076900000000006
RAYNAUD-CLAES SYNDROME; MRXSRC	0.0009615380000000001	0.048076900000000006
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.0009615380000000001	0.048076900000000006
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	0.048076900000000006
CAP MYOPATHY	0.0009615380000000001	0.048076900000000006
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.0009615380000000001	0.048076900000000006
XYLOSIDASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
SYDENHAM CHOREA	0.0009615380000000001	0.048076900000000006
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.0009615380000000001	0.048076900000000006
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.0009615380000000001	0.048076900000000006
PHELAN-MCDERMID SYNDROME	0.0009615380000000001	0.048076900000000006
HYPOTONIA-CYSTINURIA SYNDROME	0.0009615380000000001	0.048076900000000006
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.0009615380000000001	0.048076900000000006
LATHOSTEROLOSIS	0.0009615380000000001	0.048076900000000006
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0009615380000000001	0.048076900000000006
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0009615380000000001	0.048076900000000006
NIEMANN-PICK DISEASE, TYPE C2	0.0009615380000000001	0.048076900000000006
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.0009615380000000001	0.048076900000000006
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0009615380000000001	0.048076900000000006
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.0009615380000000001	0.048076900000000006
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.0009615380000000001	0.048076900000000006
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.0009615380000000001	0.048076900000000006
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0009615380000000001	0.048076900000000006
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0009615380000000001	0.048076900000000006
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.0009615380000000001	0.048076900000000006
GLYCINE ENCEPHALOPATHY; GCE	0.0009615380000000001	0.048076900000000006
MEVALONIC ACIDURIA; MEVA	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.0009615380000000001	0.048076900000000006
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.0009615380000000001	0.048076900000000006
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.0009615380000000001	0.048076900000000006
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.0009615380000000001	0.048076900000000006
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.0009615380000000001	0.048076900000000006
MARSHALL-SMITH SYNDROME; MRSHSS	0.0009615380000000001	0.048076900000000006
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.0009615380000000001	0.048076900000000006
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0009615380000000001	0.048076900000000006
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.0009615380000000001	0.048076900000000006
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.0009615380000000001	0.048076900000000006
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.0009615380000000001	0.048076900000000006
SALLA DISEASE	0.0009615380000000001	0.048076900000000006
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0009615380000000001	0.048076900000000006
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.0009615380000000001	0.048076900000000006
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0009615380000000001	0.048076900000000006
SPINOCEREBELLAR ATAXIA 13	0.0009615380000000001	0.048076900000000006
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.0009615380000000001	0.048076900000000006
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.0009615380000000001	0.048076900000000006
DDOST-CDG	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0009615380000000001	0.048076900000000006
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0009615380000000001	0.048076900000000006
PELIZAEUS-MERZBACHER DISEASE	0.0009615380000000001	0.048076900000000006
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.0009615380000000001	0.048076900000000006
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0009615380000000001	0.048076900000000006
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.0009615380000000001	0.048076900000000006
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.0009615380000000001	0.048076900000000006
PERIPHERAL HYPOTHYROIDISM	0.0009615380000000001	0.048076900000000006
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.0009615380000000001	0.048076900000000006
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, X-LINKED 1	0.0009615380000000001	0.048076900000000006
MENKES DISEASE	0.0009615380000000001	0.048076900000000006
JOUBERT SYNDROME 5	0.0009615380000000001	0.048076900000000006
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0009615380000000001	0.048076900000000006
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.0009615380000000001	0.048076900000000006
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.0009615380000000001	0.048076900000000006
SCHINDLER DISEASE, TYPE I	0.0009615380000000001	0.048076900000000006
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.0009615380000000001	0.048076900000000006
PIERSON SYNDROME	0.0009615380000000001	0.048076900000000006
SPINOCEREBELLAR ATAXIA 5; SCA5	0.0009615380000000001	0.048076900000000006
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.0009615380000000001	0.048076900000000006
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.0009615380000000001	0.048076900000000006
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.0009615380000000001	0.048076900000000006
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0009615380000000001	0.048076900000000006
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.0009615380000000001	0.048076900000000006
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0009615380000000001	0.048076900000000006
CYCLIC VOMITING SYNDROME	0.0009615380000000001	0.048076900000000006
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0009615380000000001	0.048076900000000006
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.0009615380000000001	0.048076900000000006
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.0009615380000000001	0.048076900000000006
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0009615380000000001	0.048076900000000006
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0009615380000000001	0.048076900000000006
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0009615380000000001	0.048076900000000006
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0009615380000000001	0.048076900000000006
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0009615380000000001	0.048076900000000006
METACHROMATIC LEUKODYSTROPHY	0.0009615380000000001	0.048076900000000006
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.0009615380000000001	0.048076900000000006
COFFIN-SIRIS SYNDROME 10; CSS10	0.0009615380000000001	0.048076900000000006
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0009615380000000001	0.048076900000000006
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
MAPLE SYRUP URINE DISEASE; MSUD	0.0009615380000000001	0.048076900000000006
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0009615380000000001	0.048076900000000006
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.0009615380000000001	0.048076900000000006
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0009615380000000001	0.048076900000000006
NOONAN SYNDROME 11; NS11	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.0009615380000000001	0.048076900000000006
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0009615380000000001	0.048076900000000006
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.0009615380000000001	0.048076900000000006
METHYLMALONIC ACIDURIA, CBLA TYPE	0.0009615380000000001	0.048076900000000006
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.0009615380000000001	0.048076900000000006
DESBUQUOIS DYSPLASIA 1	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.0009615380000000001	0.048076900000000006
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0009615380000000001	0.048076900000000006
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.0009615380000000001	0.048076900000000006
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.0009615380000000001	0.048076900000000006
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.0009615380000000001	0.048076900000000006
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0009615380000000001	0.048076900000000006
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0009615380000000001	0.048076900000000006
SOTOS SYNDROME 2	0.0009615380000000001	0.048076900000000006
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.0009615380000000001	0.048076900000000006
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	0.048076900000000006
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.0009615380000000001	0.048076900000000006
ADENYLOSUCCINATE LYASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.0009615380000000001	0.048076900000000006
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0009615380000000001	0.048076900000000006
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.0009615380000000001	0.048076900000000006
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0009615380000000001	0.048076900000000006
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.0009615380000000001	0.048076900000000006
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0009615380000000001	0.048076900000000006
HYPERPROLINEMIA, TYPE I	0.0009615380000000001	0.048076900000000006
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0009615380000000001	0.048076900000000006
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.0009615380000000001	0.048076900000000006
8Q24.3 MICRODELETION SYNDROME	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.0009615380000000001	0.048076900000000006
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.0009615380000000001	0.048076900000000006
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0009615380000000001	0.048076900000000006
ETHYLMALONIC ENCEPHALOPATHY	0.0009615380000000001	0.048076900000000006
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0009615380000000001	0.048076900000000006
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0009615380000000001	0.048076900000000006
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.0009615380000000001	0.048076900000000006
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0009615380000000001	0.048076900000000006
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.0009615380000000001	0.048076900000000006
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0009615380000000001	0.048076900000000006
PEROXISOME BIOGENESIS DISORDER 5B	0.0009615380000000001	0.048076900000000006
PEROXISOME BIOGENESIS DISORDER 6B	0.0009615380000000001	0.048076900000000006
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.0009615380000000001	0.048076900000000006
KETOADIPICACIDURIA	0.0009615380000000001	0.048076900000000006
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0009615380000000001	0.048076900000000006
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0009615380000000001	0.048076900000000006
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0009615380000000001	0.048076900000000006
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.0009615380000000001	0.048076900000000006
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0009615380000000001	0.048076900000000006
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
ARIMA SYNDROME	0.0009615380000000001	0.048076900000000006
PEROXISOME BIOGENESIS DISORDER 11B	0.0009615380000000001	0.048076900000000006
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.0009615380000000001	0.048076900000000006
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0009615380000000001	0.048076900000000006
RING CHROMOSOME 22 SYNDROME	0.0009615380000000001	0.048076900000000006
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.0009615380000000001	0.048076900000000006
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0009615380000000001	0.048076900000000006
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.0009615380000000001	0.048076900000000006
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0009615380000000001	0.048076900000000006
SSR4-CDG	0.0009615380000000001	0.048076900000000006
SALT-AND-PEPPER SYNDROME	0.0009615380000000001	0.048076900000000006
HUNTINGTON DISEASE-LIKE 1	0.0009615380000000001	0.048076900000000006
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0009615380000000001	0.048076900000000006
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0009615380000000001	0.048076900000000006
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.0009615380000000001	0.048076900000000006
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.0009615380000000001	0.048076900000000006
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0009615380000000001	0.048076900000000006
GLYCOGEN STORAGE DISEASE IXB	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0009615380000000001	0.048076900000000006
EPILEPSY, PYRIDOXINE-DEPENDENT	0.0009615380000000001	0.048076900000000006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0009615380000000001	0.048076900000000006
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.0009615380000000001	0.048076900000000006
TAY-SACHS DISEASE; TSD	0.0009615380000000001	0.048076900000000006
GM2-GANGLIOSIDOSIS, AB VARIANT	0.0009615380000000001	0.048076900000000006
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.0009615380000000001	0.048076900000000006
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0009615380000000001	0.048076900000000006
INFANTILE SIALIC ACID STORAGE DISEASE	0.0009615380000000001	0.048076900000000006
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.0009615380000000001	0.048076900000000006
PYRUVATE CARBOXYLASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
OSTEOGENESIS IMPERFECTA, TYPE X	0.0009615380000000001	0.048076900000000006
PEROXISOME BIOGENESIS DISORDER 3B	0.0009615380000000001	0.048076900000000006
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0009615380000000001	0.048076900000000006
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.0009615380000000001	0.048076900000000006
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.0009615380000000001	0.048076900000000006
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.0009615380000000001	0.048076900000000006
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.0009615380000000001	0.048076900000000006
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.0009615380000000001	0.048076900000000006
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0009615380000000001	0.048076900000000006
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0009615380000000001	0.048076900000000006
TEMPLE-BARAITSER SYNDROME	0.0009615380000000001	0.048076900000000006
NEURAMINIDASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
COFFIN-SIRIS SYNDROME 2; CSS2	0.0009615380000000001	0.048076900000000006
COFFIN-SIRIS SYNDROME 4; CSS4	0.0009615380000000001	0.048076900000000006
LEIGH SYNDROME; LS	0.0009615380000000001	0.048076900000000006
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.0009615380000000001	0.048076900000000006
OSTEOPENIA AND SPARSE HAIR	0.0009615380000000001	0.048076900000000006
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0009615380000000001	0.048076900000000006
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0009615380000000001	0.048076900000000006
PONTINE TEGMENTAL CAP DYSPLASIA	0.0009615380000000001	0.048076900000000006
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0009615380000000001	0.048076900000000006
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.0009615380000000001	0.048076900000000006
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0009615380000000001	0.048076900000000006
ELEJALDE DISEASE	0.0009615380000000001	0.048076900000000006
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.0009615380000000001	0.048076900000000006
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.0009615380000000001	0.048076900000000006
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.0009615380000000001	0.048076900000000006
AURICULOCONDYLAR SYNDROME	0.0009615380000000001	0.048076900000000006
JOUBERT SYNDROME 14	0.0009615380000000001	0.048076900000000006
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0009615380000000001	0.048076900000000006
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0009615380000000001	0.048076900000000006
JOUBERT SYNDROME 15	0.0009615380000000001	0.048076900000000006
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.0009615380000000001	0.048076900000000006
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.0009615380000000001	0.048076900000000006
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0009615380000000001	0.048076900000000006
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.0009615380000000001	0.048076900000000006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.0009615380000000001	0.048076900000000006
CHROMOSOME 16Q22 DELETION SYNDROME	0.0009615380000000001	0.048076900000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.0009615380000000001	0.048076900000000006
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.0009615380000000001	0.048076900000000006
NAVAJO NEUROHEPATOPATHY	0.0009615380000000001	0.048076900000000006
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0009615380000000001	0.048076900000000006
